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SUMMARY 
The overall aim of this thesis was to identify possible demographical, clinical, and 
neurocognitive risk factors for suicidal behaviour in patients with psychotic disorders.  
 
Suicidal behaviour and neurocognitive impairment are serious and prevalent problems in 
patients with schizophrenia. Studies indicate that suicidality in patients with schizophrenia 
may be associated with relatively higher neurocognitive functioning, but the findings are few 
and inconsistent. Also, behavioural- and personality measures of impulsivity have been linked 
to increased suicidal behaviour in patients with schizophrenia, but this relationship has not 
been studied by neuropsychological measures. The first aim of the present thesis was to 
investigate whether suicide attempters had higher IQ, better executive functioning, or were 
more impulsive (had poorer inhibitory control) compared to non-attempters in a group of 
patients with schizophrenia spectrum disorders. The possible confounding effect of current 
suicidality was taken into account. In a group of 174 patients with schizophrenia spectrum 
disorders, we found that there were no difference between suicide attempters and non-
attempters in IQ, executive function, impulsivity (inhibitory control), or any other 
neurocognitive domain. The presence of current suicidality did not confound the results. An 
interesting post hoc finding was that currently suicidal patients were more impulsive (had 
poorer inhibitory control) than currently non-suicidal patients, but this difference was 
mediated by positive psychotic symptoms.  
 
The suicide risk in psychotic disorders is highest in the early phases of illness. Studies have 
typically focused on suicidality from treatment start rather than the actual onset of psychosis. 
Thus, the second aim of the thesis was to explore the prevalence and characteristics of 
patients with a first episode of psychosis and suicidality in two different time intervals: 1) 
prior to study entry and 2) explicitly in the period of untreated psychosis. In a sample of 170 
patients with first episode of psychosis, we found that nearly 26% of the patients attempted 
suicide prior to study entry, and 14% made suicide attempts during the period of untreated 
psychosis. Of the patients who had been suicidal (i.e. experienced suicidal ideation or 
attempts), 70% were suicidal during the period of untreated psychosis. Suicide attempts prior 
to study entry were associated with female gender, more depressive episodes, younger age at 
psychosis onset, and history of alcohol disorder. Suicide attempts during untreated psychosis 
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were also associated with more depressive episodes and younger age at illness onset, in 
addition to drug use the last six months and longer duration of untreated psychosis (DUP).  
 
Insight has been found to be associated with increased risk for suicidal behaviour, but not 
consistently. A possible explanation for this is that insight has different consequences for 
patients depending on their beliefs about psychosis. The third aim of this thesis was to 
investigate whether a relationship between insight, negative beliefs about psychosis, and 
suicidality was mediated by depressive symptoms, and if negative beliefs about psychosis 
moderated the relationship between insight and suicidality. In a sample of 194 patients with a 
first episode of psychosis, we found that nearly 46% of the patients were currently suicidal. 
Depressive symptoms, having a schizophrenia spectrum disorder, insight, and beliefs about 
negative outcomes for psychosis were independently associated with current suicidality; 
contradicting a mediating effect of depressive symptoms. Negative beliefs about psychosis 
did not moderate the effect of insight on current suicidality.  
 
In conclusion, our results suggest that neurocognitive functioning is not essential for engaging 
in suicidal acts, at least not the neurocognitive domains measured in the present study. 
Furthermore, the prevalence of suicidality before and in the early phases of first episode 
psychosis is high, especially during untreated psychosis. As prolonged DUP is associated with 
suicide attempts during the period of untreated psychosis, reducing the DUP could have the 
effect of reducing the prevalence of suicide attempts in patients with first episode psychosis.  
Our findings also indicate that more depressive symptoms, higher insight, and negative beliefs 
about psychosis increase the risk for suicidality in patients with first episode of psychosis. 
This finding imply that monitoring insight should be part of assessing the suicide risk in 
patients with first episode psychosis, and that treating depression and counteracting negative 
beliefs about psychosis may possibly reduce the risk for suicidality.  
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1. INTRODUCTION 
Suicidal behaviour must be regarded as a disturbance of the fundamental striving to live, 
inherent in all living creatures, signifying that the individual’s ability to cope has been 
exceeded (Nordentoft, 2007). Suicide is a tragic end to an individual’s life, and a devastating 
loss to family and friends. Losing a patient to suicide is probably the worst fear of clinicians. 
Suicidal behaviour is a complex phenomenon with numerous influences, including the 
individual’s psychology, biology, culture, social and political environment (McKenzie, 
Serfaty, & Crawford, 2003). Patients with psychotic disorders have a high prevalence of 
suicidal behaviour (Radomsky, Haas, Mann, & Sweeney, 1999), and the suicide rate is 
markedly elevated compared to the general population (Saha, Chant, & McGrath, 2007). 
Bleuler (1911) noted that the most serious of all schizophrenia symptoms was the suicidal 
drive, demonstrating that the high risk for suicidal behaviour was acknowledged even among 
the earliest researchers of schizophrenia. Several variables that increase the risk for suicidal 
behaviour in psychotic disorders have been identified (Hawton, Sutton, Haw, Sinclair, & 
Deeks, 2005a), but the reason for the elevated suicide risk is still not fully understood. 
Consequently, suicide-preventing strategies are incomplete, and acquiring more knowledge 
about phenomena related to suicidal behaviour in patients with psychotic disorders is 
imperative. The overall aim of the present thesis was to identify possible risk factors for 
suicidal behaviour in patients with psychotic disorders, with a special emphasise on patients 
with a first episode of psychosis.     
 
1.1. Psychotic disorders 
1.1.1. Definitions and classifications 
The definition of the term psychosis has varied across history and is still used inconsistently.  
The narrowest definition of psychosis is restricted to a break in reality testing with distortion 
of perception (hallucinations) or thinking (delusions) with no insight into the pathological 
nature of these phenomena. Less restrictive definitions will include hallucinations that the 
individual realises are pathological, and even broader definitions will include other symptoms 
like disorganized speech and grossly disorganised or catatonic behaviour; symptoms seen in 
schizophrenia. The different psychotic disorders in the Diagnostic and Statistical Manual of 
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Mental Disorders (DSM-IV) emphasise different aspects of the diverse definitions (American 
Psychiatric Association, 1994).   
 
The contemporary classification of psychotic disorders has its origin in Kraepelin’s  (1899) 
distinction between organic and functional psychoses, with the latter category separated into  
manic-depressive insanity and dementia praecox (later named bipolar disorder and 
schizophrenia, respectively). Although Kraepelin himself later came to question the 
dichotomous classification  (Kraepelin, 1920), this view has dominated later work; bipolar 
disorder and schizophrenia have largely been viewed as discrete diseases (Crow, 1986) and 
are coded as such in the ICD-10 Classification of Mental and Behavioural Disorders (WHO, 
1993) and DSM-IV (American Psychiatric Association, 1994).  However, due to overlapping 
symptomatology, the dichotomous classification has been challenged over the last decades 
(Craddock & Owen, 2007). In addition, recent studies have found support for a common 
genetic base for schizophrenia and bipolar disorder (Craddock, O'Donovan, & Owen, 2009; 
Lichtenstein et al., 2009). Because of this, it has been suggested that the dichotomous stance 
should be departed, and an alternative view is that functional psychoses should be viewed 
along a continuum of symptoms. This debate is not yet resolved (Craddock et al., 2009), but 
studies across the functional psychosis continuum are encouraged in order to gain knowledge 
on the mechanisms of psychotic disorders (Ivleva, Thaker, & Tamminga, 2008).  
 
In this thesis, the term psychotic disorders will include non-organic disorders classified as 
Schizophrenia and other psychotic disorders in the DSM-IV (American Psychiatric 
Association, 1994), i.e. disorders with psychotic symptoms as their defining features. 
Furthermore, psychotic disorders will include disorders classified as Mood disorders with 
psychotic symptoms in DSM-IV, in which disturbance of mood is the predominant feature, 
but where psychotic symptoms are also present. The different psychotic disorders are 
distinguished based on differences in duration, dysfunction, associated substance use, 
bizarreness of delusions, and presence of depression or mania (van Os & Kapur, 2009).   
 
1.1.2. Schizophrenia 
Schizophrenia is the most prevalent and the most studied of the psychotic disorders. It is 
found universally and in all cultures (Patel, Pinals, & Breier, 2008).  Schizophrenia has a 
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relatively low median incidence rate of approximately 15 per 100 000 persons annually. 
Contrary to previously held assumptions that the rate of schizophrenia is consistent across the 
world, recent review studies have shown that incidence rates vary, with higher rates 
associated with male gender, urbanicity, and migration. The prevalence of schizophrenia also 
varies, with a median lifetime risk of developing schizophrenia of approximately 7 per 1000 
persons. Higher prevalence is found in migrants compared to native-born individuals, and in 
developed versus developing countries (McGrath, Saha, Chant, & Welham, 2008). In 
comparison, one study focused on the broader range of psychotic disorders and found that the 
lifetime prevalence of schizophrenia was nearly 1%, raising to almost 4% when the broader 
range of psychotic disorders were included (Perala et al., 2007). The specific aetiology of 
schizophrenia remains unknown, but the leading view is that several factors interact to cause 
the illness. The basis for schizophrenia is an underlying psychobiological vulnerability, 
determined by genetic and environmental factors. The genetic component is strong, with 
heritability estimates of 80%. The incidence and expression of schizophrenia is determined by 
an interplay of biological and psychosocial factors (van Os & Kapur, 2009).  
 
Patients with schizophrenia constitute a heterogeneous group. Schizophrenia is characterised 
by a variety of symptoms and signs, and several possible combinations of these may meet  the 
diagnostic criteria. Central symptoms of schizophrenia include psychotic symptoms like 
hallucinations and delusions, also called positive symptoms, as they reflect an excess or 
distortion of normal functions. Another main group of symptoms are the negative symptoms, 
reflecting a reduction or loss of normal functions, such as affective flattening, impoverished 
thinking and speech, and lack of initiative (American Psychiatric Association, 1994). 
Although not a diagnostic criterion, neurocognitive impairment is highly prevalent in patients 
with schizophrenia (Keefe, Eesley, & Poe, 2005), and impairments are found in several 
neurocognitive domains (Tandon, Nasrallah, & Keshavan, 2009). Cognitive dysfunctioning is 
a strong predictor of poor social and vocational outcome (Green, Kern, & Heaton, 2004), 
which is also a defining criterion of the schizophrenia in the DSM-IV (American Psychiatric 
Association, 1994).  As noted above, the psychotic disorders have overlapping 
symptomatology, but the features that typically distinguish schizophrenia from the other 
psychotic disorders are long duration, bizarre delusions, negative symptoms, and few 
affective symptoms (van Os & Kapur, 2009).  
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The onset of schizophrenia is usually in early adulthood; from the late teens to the mid 30’s, 
although earlier and later onset also occur (American Psychiatric Association, 1994). The 
course of the disorder is heterogeneous; positive psychotic symptoms tend to be episodic over 
time, with varying degree and duration of remission in between. Negative symptoms and 
cognitive impairments tend to be more stable over time, and can still persist in phases when 
psychotic symptoms are less prominent (Tandon et al., 2009). Treatment of schizophrenia 
typically includes antipsychotic medication and psychosocial treatment. Schizophrenia is the 
most disabling of the mental disorders and causes considerable suffering. Worldwide, 
schizophrenia is among the ten leading causes of disability, requiring a disproportionate share 
of mental health services compared to its prevalence (Mueser & McGurk, 2004). The 
traditional clinical and public view is that schizophrenia is a debilitating and deteriorating 
disorder with poor outcome (van Os & Kapur, 2009). However, the prognosis of 
schizophrenia is heterogeneous; the disorder can develop into a severe state of defect, or end 
in varying degrees of partial or full recovery (Tandon et al., 2009). Most patients need some 
degree of support, but a majority live outside of hospitals, and hospital admissions are 
typically short (van Os & Kapur, 2009). Still, schizophrenia is associated with a variety of 
serious negative outcomes, including high unemployment rates (Rosenheck et al., 2006), poor 
quality of life (Eack & Newhill, 2007), and high prevalence of comorbid mental disorders,  
including depression, substance use, and anxiety disorders (Buckley, Miller, Lehrer, & Castle, 
2009). Furthermore, schizophrenia is associated with increased mortality (Seeman, 2007),  
related to the high frequency of comorbid physical illness (Leucht, Burkard, Henderson, Maj, 
& Sartorius, 2007) and high risk of suicide (Palmer, Pankratz, & Bostwick, 2005).  
 
1.1.3. First episode psychosis 
Schizophrenia and related disorders develop through stages or phases, and the early stages 
include the premorbid phase, a prodromal phase, and the first episode of psychosis (FEP). 
While the prodromal phase is characterised by attenuated positive symptoms and declining 
function, the first episode of psychosis manifests fully fledged psychotic symptoms and marks 
the formal onset of the psychotic disorder (McGorry, Killackey, & Yung, 2007; Tandon et al., 
2009). In samples of patients with FEP, schizophrenia spectrum disorders constitute 
approximately one third of the cases (Baldwin et al., 2005; Kirkbride et al., 2006). However, 
of note is the significant degree of diagnostic instability in this population  (Baldwin et al., 
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2005; Haahr et al., 2008). Although several studies of FEP-patients include only patients with 
schizophrenia or schizophrenia spectrum disorders, the diagnostic instability is the reason for 
recommendations to include the whole range of psychotic disorders, including psychotic 
affective disorders, when studying FEP-patients (Baldwin et al., 2005).  
 
During the past 15 – 20 years, there has been a growing focus worldwide on identification and 
treatment of patients in the early phases of psychosis. These efforts were initially based on 
findings suggesting that early treatment and shorter duration of psychosis was related to better 
short-term (Falloon, 1992; Loebel et al., 1992) and long-term (Helgason, 1990) outcome. The 
first episode of psychosis can be divided into the period before and after treatment initiation.  
Studies have shown that that the period from onset of psychotic symptoms to the start of 
treatment, i.e. the period of untreated psychosis, can be disturbingly long. In patients with 
schizophrenia, the average mean duration of untreated psychosis (DUP) across different 
studies is between 1 – 2 years, and the median DUP at about 6 months (McGlashan, 1999). 
Thus, the goal in early psychosis intervention has been to minimise the DUP (McGorry et al., 
2007). Studies have shown that this is possible; e.g. Melle et al. (2004) found that FEP-
patients from an area where an early detection programme had been introduced had 
significantly shorter DUP than patients from an area without the early detection programme.  
 
The notion of a possible causal relationship between DUP and outcome has been 
controversial because of inconsistent findings, and due to arguments that the relationship is 
confounded by variables such as poor premorbid functioning or insidious illness onset, which 
could both cause delayed treatment and are associated with poor prognosis (Perkins, Gu, 
Boteva, & Lieberman, 2005). However, two comprehensive meta-analytic studies found that 
DUP was related to a range of outcome variables, including symptomatic and functional 
recovery. The effect of DUP was independent of confounders, and prolonged DUP had a 
negative effect on recovery (Marshall et al., 2005; Perkins et al., 2005). Implementing health 
services to reduce the DUP has also shown promising results on outcome. Patients in areas 
with early detection programmes, coming to treatment with shorter DUP, had significantly 
lower symptom levels than patients outside of the early detection areas, both at study entry  
and at two-year follow-up (Melle et al., 2008).  
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Despite the above mentioned findings of the negative effects of prolonged DUP and findings 
of interventions to shorten the DUP, studies indicate that the DUP continues to be long; One 
meta-study reported a mean DUP of 103 week in several studies of FEP-patients (Marshall et 
al., 2005).  
 
1.2. Suicidality  
 1.2.1. Terminology  
Suicidality may be an all-inclusive term that includes suicidal thoughts, ideation, plans, 
suicide attempts and completed suicide. However, the definition of this term varies, 
exemplifying  the conceptual debate surrounding suicidal phenomena (Silverman, 2006). In 
fact, one of the major difficulties in assessing, treating and preventing suicide is the lack of a 
consistent classification and operational definitions of suicidal behaviour (Maris, 2002). 
Neither the ICD-10 (WHO, 1993) nor in the DSM-IV (American Psychiatric Association, 
1994) have definitions of suicidal behaviour, although ICD-10 lists suicidal acts in the E-
codes (external cases of injury), and DSM-IV mentions suicidal behaviour as symptoms of 
depression and borderline personality disorder. For more than 50 years, researchers have tried 
to find satisfactory terms for the range of suicidal behaviours (Skegg, 2005), but the field is 
still characterised by unresolved challenges and controversy (Silverman, 2006). The present 
studies focused on suicidal ideation, including suicidal thoughts and suicidal plans, and 
suicide attempts. For the purpose of this thesis, only central concepts will be described.  
  
The continuum of suicide ranges from suicidal ideas to gestures, risky lifestyles, suicidal 
plans, suicidal attempts, and finally completed suicide (Maris, 2002).  Suicidal behaviour can 
be considered along two correlating dimensions; intent and lethality (Mann, 2002). Suicidal 
intent has been defined as the subjective expectation and desire for a self-destructive act to 
end in death (American Psychiatric Association, 2003), while lethality refers to the degree of 
damage resulting from a suicidal act (Mann, 2002).  
 
Definitions of suicide vary according to theoretical orientation, but four key aspects have been 
identified as inherent in the definitions: 1) outcome (death), 2) agency of the act (self-
inflicted), 3) intention to die, and 4) awareness of the outcome (Silverman, 2006); e.g. suicide 
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has been defined as  self-inflicted death with explicit or implicit evidence that the person 
intended to die (American Psychiatric Association, 2003).  
 
Non-fatal suicidal acts are described by several partly overlapping concepts (Skegg, 2005). 
The term suicide attempt has been defined as self-injurious behaviour with non-fatal outcome 
accompanied by explicit or implicit evidence that the person intended to die (American 
Psychiatric Association, 2003). Although definitions of attempted suicide also vary, they 
usually include reference to self-injurious behaviour with the intent to die. Alternative terms 
like parasuicide and deliberate self-harm (DSH) are generally applied to self-injurious 
behaviour regardless of the presence of suicidal intent. Hence, these terms are more 
heterogeneous and include a wider range of behaviour than suicide attempt (Silverman, 2006). 
In the present studies, we have focused on suicide attempts rather than DSH or parasuicide as 
suicide attempt is a more specific concept.  
 
Suicidal ideation indicates no suicidal acts, and has been defined as thoughts of serving as the 
agent of one’s own death. Suicidal ideation may vary in seriousness depending on the 
specificity of suicidal plans and degree of suicidal intent (American Psychiatric Association, 
2003), indicating that suicidal ideation includes thoughts with or without a suicidal plan. 
Suicidal plan is a frequently used but rarely defined concept. However, it is often equated to 
having a suicide method (McKeon, 2009).  
 
1.2.2. Prevalence of suicidal behaviour 
Suicide is considered a significant public health problem. Self-inflicted death accounts for 
1.5% of all deaths, and suicide is the tenth leading cause of death worldwide (Levi et al., 
2003). The “global” annual suicide rate is 16 per 100 000 persons, and suicide is the third 
leading cause of death in the 15 – 44 year age group in some countries (WHO, 2010). In 
general, difficulties in discriminating suicides from accidental deaths probably cause official 
suicide rates to underestimate actual suicide rates (Nordentoft, 2007).  
 
Suicide rates vary considerably between regions and countries. The lowest annual rates are 
reported in Latin America and Muslim countries, with fewer than 6.5 suicides per 100 000 
persons. The highest rates are registered in Eastern Europe, where several countries report 
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more than 27 suicides per 100 000 per year (Mann et al., 2005). The UK and USA have 
suicide rates in the mid-range with rates per 100 000 of 12 for men and 3 for women in the 
UK, and 18 and 4 respectively in the USA (McKenzie et al., 2003). Within Europe, rates are 
generally higher in the north compared to the south, but countries at the same latitude can 
have very different rates (Hawton & Van Heeringen, 2009). In the Nordic countries, there are 
small differences between Norway, Iceland, Sweden and Denmark, with suicide rates of 12 – 
14 per 100 000. Finland, however, have a much higher rate of 24 per 100 000 (Norwegian 
Institute of Public Health, 2009).   
 
Comparison of suicide rates across different countries should be approached with caution. 
Countries differ in their death certification practices, and in requirements for a death to be 
recorded as a suicide. In some countries, suicide is illegal, which may probably affect 
registration practices. And in some parts of the world, epidemiological data on suicide is 
scarce (Hawton & Van Heeringen, 2009). However, differences in suicide rates between 
countries are not merely the result of registration biases; several studies show that suicide 
rates in immigrants tend to be more similar to rates in their native country than to rates in their 
current country of residence (Burvill, 1998; Malenfant, 2004), indicating that culture and 
ethnicity influence on suicide rates (Mann, 2002).  In addition to regional differences, clear 
ethnic patterns in suicide rates are demonstrated. For instance, Native Americans have more 
than 50% higher suicide rates than European Americans, who have much higher suicide rates 
than Hispanic and African Americans (McKenzie et al., 2003).   
 
Suicide rates also differ across time, age and gender. The rates are highest in elderly people in 
most countries, but over the past 50 years, rates have risen in the young, particularly in men 
(Wasserman, Cheng, & Jiang, 2005), and decreased in elderly people (Pritchard & Hansen, 
2005). In Norway, suicide rates increased from the end of the 1960’s to the end of the 1980’s, 
followed by a 25% decrease in the suicide rate between 1988 and 1994. From 1994 the 
suicide rates have been relatively stable with a mean level of 12 pr 100 000 per persons 
annually, with no significant differences between persons over the age of 20 (Norwegian 
Institute of Public Health, 2009). In most regions of the world, men complete suicide more 
often than women do. The ratio of men to women is between two and four to one (Hawton & 
Van Heeringen, 2009). Attempted suicide is, however, more prevalent among women than 
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men worldwide, with few exceptions  (Kerkhof, 2000).  This could reflect the tendency for 
men to choose more lethal methods (e.g. hanging, shooting), while women tend to choose less 
violent means (e.g. self-poisoning) (Denning, Conwell, King, & Cox, 2000).   
 
While many countries monitor deaths by suicide, no national or international surveillance 
system exists for monitoring the occurrence of suicide attempts (Silverman, Berman, Sanddal, 
O'carroll, & Joiner, 2007).  However, non-fatal suicidal behaviours are believed to occur at a 
far higher rate than completed suicide; it is estimated that there are 10 – 25 non-fatal suicide 
attempts for every completed suicide (Maris, 2002). Suicidal ideation without action is even 
more common than suicidal acts (Mann, 2002). For instance, nearly 15% of American youths 
reported having seriously considered suicide within the previous year, and 40% of adults with 
depression wanted to kill themselves during their worst or most recent depressive episode 
(McKeon, 2009).  
 
1.2.3. The development from suicidal ideation to suicidal acts 
There is little research to describe how processes develop from suicidal ideation to actual 
suicidal acts (Silverman et al., 2007). Not surprisingly, however, research indicates that in 
general, different suicidal expressions are related to each other. Studies show that suicidal 
thoughts are related to increased risk for making suicide attempts (Kuo, Gallo, & Tien, 2001), 
and the risk for attempting suicide is significantly higher among individuals with a suicidal 
plan compared to individuals with suicidal thoughts (Borges et al., 2006; Kessler, Borges, & 
Walters, 1999). Furthermore, previous self-harm and suicide attempts increase the risk for 
later attempts. In prospective studies, between 0.5% and 2% of people who self-harm die by 
suicide within the first year, and more than 5% died within nine years (Owens, Horrocks, & 
House, 2002), with increased risk for individuals who repeated self-harm (Zahl & Hawton, 
2004).  One study of individuals who had made serious suicide attempts found a suicide rate 
of almost 7% after five years, while more than 37% had made at least one additional non-fatal 
suicide attempt (Beautrais, 2004). In most studies, a history of self-harm or suicide attempts is 
the strongest risk factor for death by suicide, present in approximately 40% of individuals 
who die by suicide (Cavanagh, Carson, Sharpe, & Lawrie, 2003; Hawton & Van Heeringen, 
2009).   
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 1.2.4. Suicidality and psychiatric illness 
Suicide is strongly associated with psychiatric illness. Studies, mainly from Europe and North 
America, show that more than 90% of individuals who complete suicide have a mental 
disorder at the time of death (Bertolote, Fleischmann, De, & Wasserman, 2004; Cavanagh et 
al., 2003).  Mood disorders are most commonly associated with suicide, followed by 
substance use-related disorders, schizophrenia, and personality disorders (Bertolote et al., 
2004). Comorbidity of disorders increases the suicide risk.  
 
More than half of the individuals who complete suicide have a current depressive disorder 
(Cavanagh et al., 2003). Approximately 4% of all depressed individuals die by suicide 
(Coryell & Young, 2005), and the risk is higher in patients hospitalised with depression 
(Bostwick & Pankratz, 2000). The risk is highest in the first episode of depression, possibly 
related to alcohol misuse, impulsivity, and aggressiveness, which seem to affect suicide in 
children and adolescents (McGirr et al., 2008). Risk factors associated with suicide in patients 
with major depression are high levels of hopelessness, high overall levels of suicidal 
tendencies, and history of attempted suicide (Coryell & Young, 2005).   
 
Of patients with bipolar disorder, 10 – 15% die bye suicide, most often early in the illness 
course (Hawton & Van Heeringen, 2009). As with depressive disorder, the main risk factors 
related to suicide in bipolar disorder are previous suicide attempts and feelings of 
hopelessness (Hawton, Sutton, Haw, Sinclair, & Harriss, 2005b).  
 
Substance misuse, and especially alcohol, is also strongly associated with suicide risk. A 
review of research showed that on average, 40% of suicide attempters and 37% of individuals 
who died by suicide had acute alcohol use (Cherpitel, Borges, & Wilcox, 2004). The suicide 
risk increases with severity of alcohol misuse, and thus the risk is higher for alcohol 
dependency than alcohol abuse, with an estimated suicide risk of 7% for patients with alcohol 
dependency. Predisposing factors for suicide related to alcohol dependency seem to be 
aggression, impulsivity, and hopelessness, while depression and stressful life events are key 
precipitating factors (Conner & Duberstein, 2004). Far more research has focused on alcohol 
than any other drug in relation to suicidal behaviour (McKeon, 2009). However, a variety of 
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other drugs have also been shown to be present at the time of suicide (Karch, Barker, & 
Strine, 2006).  
 
Approximately 30 – 40% of all suicides are completed by individuals with a personality 
disorder, with an increased risk for borderline and antisocial personality disorders (Duberstein 
& Conwell, 1997), characterised by emotional lability, aggression, and impulsivity (Mann, 
2002). However, most suicide completers with personality disorders have coexisting 
depressive symptoms, substance misuse, or both (Hawton & Van Heeringen, 2009).  
 
Finally, the risk for suicide is also high in patients with schizophrenia (Palmer et al., 2005), 
and suicidality in psychotic disorders is the focus of the next chapter.  
 
1.3. Suicidality in psychotic disorders 
1.3.1. Prevalence of suicidal behaviour in psychotic disorders 
The high frequency of suicidal attempts and completed suicide in patients with schizophrenia 
is well established. Studies also show that suicidal behaviour is prevalent in other psychotic 
disorders (Radomsky et al., 1999). There is a large literature on suicidality in affective 
disorders (i.e. depressive disorder and bipolar disorder), but few studies have specifically 
addressed psychotic affective disorders. Taken as a whole, most research on suicidality in 
psychotic disorders has focused on schizophrenia.  
 
Suicide is the single leading cause of premature death among patients with schizophrenia 
(Brown, 1997), who have 12 times the risk of dying by suicide compared to the general 
population (Saha et al., 2007). Estimates indicate that 5 - 13 % of patients with schizophrenia 
will kill themselves (Caldwell & Gottesman, 1990; Palmer et al., 2005). These estimates vary 
due to different methodology; the 13% risk is an estimate of proportionate mortality, i.e. the 
percentage of the dead who died by suicide, while the 5% risk reflects case fatality, i.e. the 
percentage of the original sample who died by suicide. Proportionate mortality provides 
information only about the subjects in a study who are dead, but no information about 
subjects who are still alive. The use of proportionate mortality estimates poses a particular 
problem in schizophrenia and other psychotic disorders, because these disorders often have an 
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early age of onset (American Psychiatric Association, 1994), and the risk for suicide is 
highest in the early phases of illness (Palmer et al., 2005). The subjects who have survived the 
initial period of increased risk, have not yet entered the period of elevated risk of death from 
other causes. Thus, proportionate mortality assumes a constant suicide risk over the lifetime 
and will overestimate the suicide risk. As case fatality rates look at number of suicides as a 
fraction of the total sample, these rates are considered more accurate estimates of suicide 
prevalence than proportionate mortality. Accordingly, the lifetime risk for suicide in patients 
with schizophrenia is considered to be approximately 5% (Palmer et al., 2005). The 
prevalence of non-fatal suicidal behaviour is much higher; suicidal ideation and suicide 
attempts occur in as many as 50% of the patients with schizophrenia (Bolton, Gooding, 
Kapur, Barrowclough, & Tarrier, 2007).  
 
1.3.2. Non-fatal suicidal behaviour 
Suicidal symptoms are an additional burden for patients struggling with psychotic and related 
symptoms. In addition, suicidal ideation and suicide attempts are most likely distressing for 
relatives and health personnel. The study of non-fatal suicidal behaviour is thus important in 
its own right. However, the most important goal in studying suicidality is to prevent 
individuals from completing suicide. Despite this, we have focused on non-fatal suicidal 
behaviour in the present studies, i.e. suicidal ideation and suicide attempts. The reason for this 
is that psychotic disorders are infrequent, and even though patients with psychotic disorders 
have an increased suicide risk, completed suicide is relatively rare. To study completed 
suicide would involve recruitment of numbers of participants so large that it is practically 
impossible (Meltzer et al., 2003). Alternatively, completed suicide can be investigated in 
psychological autopsy studies, retrospectively collecting all available information about 
persons who died by suicide. This method, however, has some serious methodological 
challenges regarding the amount and accuracy of available data (Hawton et al., 1998). 
Consequently, the study of non-fatal suicidal behaviour as a proxy for completed suicide is 
widespread. In favour of this approach is the view that suicidal ideation and plans are 
important steps in a process that could lead to suicide attempts and possibly death 
(Kontaxakis et al., 2004). There are also studies supporting a relationship between different 
suicidal expressions in patients with psychotic disorders. Suicidal ideation has been associated 
with increased risk of suicide attempts (Harkavy-Friedman et al., 1999; Nordentoft et al., 
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2002) and completed suicide, and attempted suicide is a strong predictor of later attempts and 
completed suicide (Hawton et al., 2005a). This indicates that suicidal phenomena of lower 
severity may serve as early warnings for more severe suicidality (Fialko et al., 2006).  
 
1.3.3. Risk factors for suicidal behaviour in psychotic disorders 
 A number of different theoretical models of suicide in general has been suggested (Bolton et 
al., 2007). However, it has been argued that all models of suicidal behaviour in the end have 
to answer the question regarding which variables contribute to long term vulnerability (trait 
factors), and which represent short-term precipitating factors (state factors). As it turns out, 
some variables related to suicidality can be both trait- and state dependent (Williams, Crane, 
Barnhofer, & Duggan, 2005). Furthermore, it is unclear whether all variables related to 
increased risk in the general population also constitute a risk for patients with psychotic 
disorders (McGirr & Turecki, 2008). Still, identifying risk factors for suicidal behaviour is an 
important approach in the effort to predict and prevent suicide (Pompili et al., 2007).  
 
A large body of research has identified variables that increase the risk for suicidal behaviour, 
and the following apply both to the general population (Hawton & Van Heeringen, 2009; 
Maris, 2002) and to patients with psychotic disorders. The most consistent demographical risk 
factors are being white and male (Hawton et al., 2005a; Montross, Zisook, & Kasckow, 
2005), although the gender differences are less in schizophrenia than in the general population 
(Harkavy-Friedman & Nelson, 1997). The most important clinical risk factor is previous 
attempted suicide, significantly increasing the risk for later completed suicide. Greater 
lethality of the attempt and fewer measures taken for being rescued are also indicative of 
strong intent. Other major clinical risk factors are depression, both history of depression and 
recent depression, and feelings of hopelessness. The presence of drug misuse or -dependency 
also significantly increases the suicide risk (Hawton et al., 2005a; Montross et al., 2005). In 
view of the strong relationship between alcohol use and suicide in the general population, it is 
surprising to find that this relationship has been inconsistently reported in patients with 
psychotic disorders (Hawton et al., 2005a; Pompili et al., 2007). However, lack of social 
support is frequently noted as a risk factor (Montross et al., 2005) in both populations.  
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While the above mentioned risk factors are also found in the general population, some risk 
factors seem to be specific to psychotic disorders. Suicides happen at a younger age in 
patients with schizophrenia compared to the general population, with the highest risk 
occurring  in the age range 22 – 40 years (Montross et al., 2005). This is consistent with the 
higher suicide risk early in the course of the disorder (McGirr & Turecki, 2008; Palmer et al., 
2005). Patients with more severe illness courses have an increased risk for suicide; i.e. 
patients with more frequent and longer hospitalisations, more relapses and/or higher doses of 
antipsychotic medication. Patients with schizophrenia also have a higher risk for suicide 
within the first few weeks or months after discharge from hospital, which could be due to 
post-psychotic depression (Montross et al., 2005). It is also found that poor adherence to 
treatment, both medical treatment and attending follow-up, has been related to considerable 
increased suicide rate (Hawton et al., 2005a). Some studies find that the presence of active 
psychotic illness is related to suicide (Heila et al., 1997; McGirr et al., 2006; Westermeyer, 
Harrow, & Marengo, 1991), while reviews report of heterogeneous findings and a non-
relationship between active illness and suicide. The relationship between suicide and specific 
positive symptoms like delusions and hallucinations has also been studied, but again with 
inconsistent findings (Hawton et al., 2005a; Montross et al., 2005). A few studies report of 
patients who have attempted suicide (Harkavy-Friedman et al., 2003) or completed suicide 
(Zisook, Byrd, Kuck, & Jeste, 1995) as a result of command hallucinations, but this occurs 
rarely and seems to be the exception rather than the rule (Montross et al., 2005). In sum, the 
role of psychotic symptoms in relation to suicide seems unresolved. However, it has been 
indicated that assumed consequences of psychotic disorders, i.e. fear of mental disintegration, 
increase the risk for suicide (Hawton et al., 2005a).  
 
The prevalence of suicide attempts is higher then the rate of completed suicide. This could 
indicate that risk factors for attempted suicide are not the same as for completed suicide 
(McGirr & Turecki, 2008). However, most reviews have focused on suicide rather then 
suicide attempts. One study has reviewed risk factors for DSH in patients with schizophrenia, 
that is, risk factors for any acts of deliberate self-poisoning or self-injury (Haw, Hawton, 
Sutton, Sinclair, & Deeks, 2005). This study found that DSH was associated with suicidal 
ideation, previous DSH, past depressive episodes, drug abuse or drug dependency, and high 
number of psychiatric admissions; much resembling the above-mentioned variables 
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frequently associated with completed suicide. However, differences in risk factors for 
attempted and completed suicide have also been indicated. In the general population and in 
other clinical populations, men complete suicide more often than women, while women make 
more suicide attempts than men do. In patients with schizophrenia, the suicide rate is also 
higher in men, but when it comes to suicide attempts, the gender ratio seem to be more evenly 
distributed  (Harkavy-Friedman & Nelson, 1997). Furthermore, suicide completers with 
schizophrenia have been shown to differ from attempters in being more depressed, hopeless, 
and socially isolated (Drake, Gates, & Cotton, 1986). Hence, risk factors for attempted suicide 
do not seem fully consistent with risk factors for completed suicide.  
 
In sum, several risk factors for suicidal behaviour in schizophrenia and related disorders have 
been identified. However, it has been argued that these are of limited value in clinical practise 
because they are common phenomena and thus  characterise a large group of people, 
including patients not at risk for suicide (Bolton et al., 2007). It is possible that gaining more 
knowledge about variables explicitly related to suicidality in patients with psychotic disorders 
will facilitate the identification of patients who are at actual risk for engaging in suicidal 
behaviour.  
 
1.3.4. Neurocognitive function and suicidality in psychotic disorders 
Neurocognitive impairment is an important component of schizophrenia (Keefe & Fenton, 
2007), existing independently of clinical symptoms (Keefe et al., 2006) and neuroleptic 
medication (Torrey, 2002).  Neurocognitive dysfunctions are highly prevalent in this patient 
group, although to varying degrees (Keefe et al., 2005). Impairments are found throughout the 
course of the disorder, i.e. in individuals at risk for developing schizophrenia (Erlenmeyer-
Kimling et al., 2000), in the premorbid phase (Woodberry, Giuliano, & Seidman, 2008), in 
first-episode schizophrenia (Bilder et al., 2000), and in chronic schizophrenia (Harvey et al., 
1999). Patients with schizophrenia have shown to have impairments in a range of 
neurocognitive domains, including episodic memory, processing speed, verbal fluency, 
attention, and executive function and working memory. The impairments appear to be more 
severe and persistent in patients with schizophrenia compared to patients with affective 
disorders, but not qualitatively different (Tandon et al., 2009). The significance of 
neurocognitive dysfunction seems to be substantial; several studies have shown that 
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neurocognitive impairments are related to several global and specific functional outcomes, 
e.g. poor social and occupational outcome, contributing to difficulties in managing daily 
activities (Green et al., 2004).  
 
Suicidality in schizophrenia has been associated with higher IQ (De Hert, McKenzie, & 
Peuskens, 2001; Fenton, 2000), but not consistently (Kim, Jayathilake, & Meltzer, 2003; 
Nangle et al., 2006; Potkin, Anand, Alphs, & Fleming, 2003). IQ is a measure of global 
cognitive function. Few studies have investigated the relationship between more specific 
neurocognitive domains and suicidal behaviour in schizophrenia, and with inconsistent 
findings. Potkin et al. (2003) did not find a relationship between any specific neurocognitive 
domains and suicidality.  Kim et al. (2003) found that patients with a history of lifetime 
suicidality performed better than patients without lifetime suicidality on measures of 
psychomotor speed, attention, working memory verbal fluency, verbal memory, and executive 
function, but this difference was mediated by feelings of hopelessness. Finally, Nangle et al. 
(2006) found that suicide attempters had better functioning than non-attempters on sub-
components of executive functioning (attention and verbal fluency). Executive function 
includes volition, planning, purposive action, and self-monitoring of behaviour (Green, Kern, 
Braff, & Mintz, 2000). As impairment in executive processes could result in failure to 
formulate, plan and choose goal-directed actions, Nangle et al. (2006) have suggested that 
better executive functioning could imply better abilities to plan and initiate suicidal acts.  
 
Impulsivity has also been hypothesised to predispose for suicidal behaviour  (Mann, 
Waternaux, Haas, & Malone, 1999). The conceptualization of impulsivity varies, but there is 
some agreement that the general features of impulsive behaviour include rapid, spontaneous, 
ill-planned, excessive, and potentially maladaptive conduct  (Enticott & Ogloff, 2006). An 
association between increased behavioural impulsivity and suicidality has been indicated in 
patients with schizophrenia (De Hert et al., 2001). In addition, personality measures of 
impulsivity have been associated with increased suicidal risk in several psychiatric disorders 
(Brezo, Paris, & Turecki, 2006), including schizophrenia  (Gut-Fayand et al., 2001), though 
not consistently (McGirr et al., 2006). Personality measures of impulsivity typically rely on 
self-reports of previous impulsive behaviour, e.g. the Barratt Impulsiveness Scale (Patton, 
Stanford, & Barratt, 1995). Unlike neuropsychological measures, self-reports have the 
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advantage of assessing impulsivity across various settings, and may include reports of 
impulsivity in real-life settings. However, self-report measures assume that aspects of 
impulsivity, both cognitive processes and behaviour, are conscious to the individual. 
Furthermore, social desirability may influence the responses. Another concern is whether 
impulsive individuals, who by definition may present impulsive and incorrect responses, will 
provide valid answers to questions that depend on complex retrieval and summary of 
behaviours (Enticott & Ogloff, 2006). Accordingly, it has been suggested that the use of 
neuropsychological measures of impulsivity could prove to be more sensitive (Mann et al., 
1999) and objective (Enticott & Ogloff, 2006) than clinical measures.  
 
The ability to inhibit inappropriate responses is a key component of executive function 
(Cheung, Mitsis, & Halperin, 2004), and dyscontrol of inhibition is suggested to be a possible 
underlying cause of impulsivity. Hence, neuropsychological measurements of impulsivity 
commonly involve paradigms in which inappropriate responses must be inhibited (Enticott & 
Ogloff, 2006). A recent study found a relationship between inhibitory dyscontrol and 
personality measured impulsivity in a non-clinical sample (Enticott, Ogloff, & Bradshaw, 
2006). Furthermore, impaired inhibition has been related to suicidality in different samples, 
including samples of bipolar disorder and mixed psychiatric disorders (Dougherty et al., 2004; 
Horesh, 2001; Raust et al., 2007; Swann et al., 2005; Wu et al., 2009). To our knowledge, no 
studies of this relationship have focused solely on patients with schizophrenia. 
 
A model of suicidal behaviour has been proposed in which the risk for suicidal acts is 
influenced by individual trait-like predispositions (Mann et al., 1999). As neurocognitive 
impairments in schizophrenia are considered to be relatively stable over time (Heaton et al., 
2001), neurocognitive differences between suicide attempters and non-attempters could 
elucidate trait differences that predispose for suicidal acts. However, since impaired 
neurocognitive functioning has been related to current suicidal state, investigation of the 
relationship between lifetime suicide attempts and neurocognitive traits needs to consider the 
possible confounding effect of current suicidality (Bryan, 2007).  
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1.3.5. Early psychosis and risk for suicidality 
The reason for the high prevalence of suicidal behaviour in patients with psychotic disorders 
could be the strain of having psychotic symptoms over time, and the negative outcomes of the 
disorders.  In view of this, it is surprising that the risk for suicide is highest in the early phases 
of the disorder (Palmer et al., 2005). Most suicides occur within the first decade after illness 
onset, and approximately 50% take place within the first two years of the disorder (Montross 
et al., 2005).  
 
Studies of psychotic disorders have typically focused on suicidality in relation to treatment 
start rather than the actual onset of psychosis. However, risk factors for suicidal behaviour 
like depression (Hawton et al., 2005a) and substance use (Verdoux et al., 2001)  are prevalent 
before treatment start (Larsen et al., 2006; Romm et al., 2010), indicating that the time before 
treatment start could be a period of increased suicide risk. In fact, studies have found that 14 – 
28% of patients with FEP have attempted suicide prior to first treatment for psychosis 
(Bertelsen et al., 2007; Robinson et al., 2009). In addition, it appears that patients with 
untreated psychosis have a higher risk for violent suicide attempts compared to treated 
patients (Nielssen & Large, 2009). The relevance of directing attention to the period before 
treatment start is also indicated in a study finding that FEP-patients from an area with an early 
detection programme, involving coming to treatment at an earlier phase of the disorder and 
with lower symptom levels, reported less severe suicidality than patients from areas without 
the detection programme (Melle et al., 2006).  
 
A few studies have focused on suicidality explicitly in the period between psychosis onset and 
treatment start, i.e. during the period of untreated psychosis. Within this period, 7 – 11% of 
patients with a FEP attempted suicide (Clarke et al., 2006; Foley et al., 2008) or engaged in 
self-harm (Harvey et al., 2008). As noted above, the duration of untreated psychosis can be 
alarmingly long (McGlashan, 1999). Some studies find that longer DUP is associated with 
increased risk for suicidal behaviour (Altamura, Bassetti, Bignotti, Pioli, & Mundo, 2003; 
Clarke et al., 2006; Harvey et al., 2008), though not consistently (Bakst, Rabinowitz, & 
Bromet, 2009; Foley et al., 2008; Nordentoft et al., 2002; Preti, Meneghelli, Pisano, & 
Cocchi, 2009). There is some evidence that risk factors for suicidal behaviour vary across 
different phases of illness (Addington, Williams, Young, & Addington, 2004; Clarke et al., 
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2006). The reason for the inconsistent association between DUP and suicidal behaviour could 
be that the studies measure suicidality in different time intervals. To investigate this issue, 
DUP and suicidality in patients with psychotic disorders should be compared across 
specifically defined periods.  
 
 1.3.6. Insight into psychosis 
Insight in psychosis encompasses the patients’ experience of their disorder. Traditionally, 
insight was viewed as a unitary concept and an all-or none phenomenon. More recently, 
insight is viewed as a multidimensional and continuous construct. David (1990) defined 
insight along three overlapping dimensions: the individual’s recognition of having a mental 
illness, compliance with treatment, and ability to relabel unusual mental events as 
pathological. Poor insight, also called “lack of awareness”, is considered a key feature of 
psychosis, and has by many been seen as the actual defining characteristic of psychotic 
disorders (McGorry & McConville, 1999). Studies report that as many as 50 – 80 % of 
patients with schizophrenia do not believe they have a disorder  (Amador & Gorman, 1998). 
Poor insight is found in all psychotic disorders, and most pronounced in schizophrenia and 
bipolar disorder (Amador et al., 1994; Pini, Cassano, Dell'Osso, & Amador, 2001). However, 
lack of insight does not seem to be a static phenomenon. Although it may persist in some 
patients (Cuesta, Peralta, & Zarzuela, 2000), insight may also improve during treatment 
(Wiffen, Rabinowitz, Lex, & David, 2010).  
 
Poor insight is one of the main causes of treatment non-adherence in patients with 
schizophrenia (Lacro, Dunn, Dolder, Leckband, & Jeste, 2002), and is thus considered to be 
an important clinical variable. However, overall, insight has been found to have apparently 
contradictory associations with outcome. Higher insight has been associated with lower 
symptom levels (Mintz, Dobson, & Romney, 2003) and with better treatment adherence, 
social functioning (Olfson, Marcus, Wilk, & West, 2006), and better work performance 
(Lysaker, Bryson, & Bell, 2002). But in addition, higher insight has been associated with 
more depression (Mintz et al., 2003), hopelessness (Carroll, Pantelis, & Harvey, 2004), and 
lower quality of life (Hasson-Ohayon, Kravetz, Roe, David, & Weiser, 2006). Insight has also 
been related to suicidal behaviour, but again with inconsistent findings; several studies show 
that presence of insight increases the risk for suicidal behaviour (Foley et al., 2008; Robinson 
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et al., 2009), while other studies find that only some aspects of insight are related to increased 
risk (Amador et al., 1996; Crumlish et al., 2005; Schwartz & Smith, 2004). There are also 
studies that do not find a relationship between insight and suicidality (Hawton et al., 2005a; 
Restifo, Harkavy-Friedman, & Shrout, 2009), and studies that report a protective effect of 
insight (Bourgeois et al., 2004; Steblaj, Tavcar, & Dernovsek, 1999). One possible 
explanation for the apparently contradictory findings between insight and outcome is that the 
impact of insight into psychotic disorders depends on the meanings attached to the disorder 
(Lysaker, Roe, & Yanos, 2007), i.e. the patients beliefs about psychosis.  
 
1.3.7. Beliefs about psychosis 
While insight into psychosis involves acceptance of a personal illness, regardless of 
knowledge and facts about of the illness (David, 1990), beliefs about psychosis are cognitions 
about psychotic disorders (Linden & Godemann, 2007), for instance about causation, 
treatment options, and prognosis. In general, beliefs about psychotic disorders seem to be 
highly negative. Of the psychotic disorders, most studies have focused on schizophrenia, 
which appear to be among the most stigmatized of the mental disorders (Crisp, Gelder, Rix, 
Meltzer, & Rowlands, 2000). People with schizophrenia are considered unpredictable and 
dangerous, and they elicit uneasiness, uncertainty, and fear in other people. Pessimistic beliefs 
about the course of schizophrenia prevail. In addition, very negative views about 
pharmacological treatments for mental disorders are common (Angermeyer & Dietrich, 
2006). Media may at least partly be responsible for the prevalent negative beliefs; media 
coverage of schizophrenia is often negatively laden, including common use of stigmatising 
descriptors and frequently linking schizophrenia to violent events without putting the risk of 
violence into perspective (Clement & Foster, 2008). It is believed that beliefs about illness 
shape the emotional responses to illness and health-related behaviour (Salmon, 2000). In 
keeping with this view, studies have shown that psychoeducation for schizophrenia and 
related illnesses, with the intent to enhance the patients’ knowledge of their illness, is related 
to reduced relapse or readmission rates, and a positive effect on the patients’ well being 
(Pekkala & Merinder, 2002). It is not unlikely that patients who receive a diagnosis of 
schizophrenia or a related disorder will be influenced by the existing negative beliefs about 
schizophrenia. Studies show that negative illness perceptions have been related to depression 
and post-psychotic depression, anxiety, and low self-esteem (Iqbal, Birchwood, Chadwick, & 
  
29 
 
Trower, 2000; Karatzias, Gumley, Power, & O'Grady, 2007; Watson et al., 2006). In addition, 
negative illness perceptions have been related to suicidality (Fialko et al., 2006).  
1.3.8. Insight, beliefs about psychosis, and suicidality 
It is possible that the impact of insight on suicidality depends upon the individual’s beliefs 
about psychosis. For instance, if the patient believes that a psychotic disorder means a chronic 
condition with deteriorating mental state, and that aspirations no longer can be achieved, then 
insight could possibly lead to depression, hopelessness and suicidal behavior. However, if the 
patient does not believe that psychosis prevents chances for a satisfying life, insight may not 
lead to the same pessimism.  In support of this, studies have found that beliefs about 
psychosis moderate the relationship between insight and other aspects of outcome; i.e. 
patients with high insight accompanied by stigmatizing beliefs about mental illness have less 
hope, lower self-esteem, lower quality of life and more depression compared to patients with 
high insight and fewer stigmatizing beliefs (Lysaker et al., 2007; Staring, Van der Gaag, Van 
den Berge, Duivenvoorden, & Mulder, 2009). So far, no studies have focused on insight and 
beliefs about psychosis in relation to suicidality. This relationship seems especially relevant to 
explore early in the course of psychotic disorders when the suicide risk is highest. Also, 
insight, negative beliefs, and suicidality have all been related to depression (Beck, 2005; 
Hawton et al., 2005a; Mintz et al., 2003), which is especially prevalent in this phase of 
psychotic disorders (Romm et al., 2010). Finally, beliefs about psychosis may be particularly 
relevant to study in patients who have recently been faced with the reality of having a 
psychotic disorder, as it is likely that they hold the same negative beliefs about psychosis 
observed in the general population.  
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2. AIMS OF THE THESIS 
The overall aim of the present thesis was to identify possible risk factors for suicidal 
behaviour in patients with psychotic disorders. As the risk for suicidal behaviour is highest in 
the early phases of psychotic disorders, the thesis focuses primarily on patients with a first 
episode of psychosis.  
 
The aim of the first study was to investigate whether lifetime suicide attempters had better 
global cognitive functioning (higher IQ), better executive functioning, or higher impulsivity 
(poorer inhibitory control) than non-attempters in patients with schizophrenia spectrum 
disorders. The possible confounding effect of current suicidality on the relationship between 
neurocognitive performance and lifetime suicide attempts was taken into account. 
 
The aim of the second study was to explore the prevalence and characteristics of patients with 
a first episode of psychosis and suicidality in two different time intervals: 1) prior to study 
entry and 2) explicitly in the period of untreated psychosis. As previous attempted suicide is a 
strong predictor of later attempts and completed suicide (Hawton et al., 2005a), we focused 
particularly on suicide attempts in the two time intervals.  
 
The aim of the third study was to explore the relationship between insight, beliefs about 
psychosis, depressive symptoms, and current suicidality in patients with first episode 
psychosis. In particular, we investigated whether a relationship between insight, negative 
beliefs about psychosis, and suicidality was mediated by depressive symptoms. Furthermore, 
we predicted that beliefs about psychosis would moderate the effect of insight on suicidality, 
i.e. we expected that higher insight would be associated with current suicidality in patients 
with negative beliefs about psychosis, but not in patients without negative beliefs about 
psychosis.  
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3. MATERIAL AND METHODS  
3. 1. Setting  
The present studies were part of the Thematically Organized Psychosis research (TOP) study, 
a large translational research study affiliated with the University of Oslo. The overall aim of 
the TOP study is to investigate clinical and biological characteristics of psychotic disorders in 
order to gain more knowledge about pathophysiological mechanisms. Patients included in the 
TOP study were recruited consecutively from in- and out patient psychiatric units in four 
hospitals in the Oslo region, covering a catchment area of 485 000 inhabitants, and Innlandet 
Hospital Trust, covering the neighbouring counties of Hedmark and Oppland, a catchment are 
of 374 500 inhabitants. Taken together, these catchment areas cover urban, suburban and rural 
areas. Mental health care in Norway is organized in catchment areas,  offering public mental 
health care to all individuals within a given catchment area, and resulting in a high degree of 
patient representativity. Patient inclusion started in October 2002 and is still ongoing. The 
TOP study aims at including all patients with psychotic disorders in treatment at the 
cooperating hospitals, but the main diagnostic categories included in the TOP study are 
schizophrenia- and bipolar spectrum disorders. The TOP study collects clinical and 
neurocognitive data, data from structural and functional MRI, and genetic information. The 
present studies are based on clinical and neurocognitive data from the TOP study.  
 
3.2. Design 
The present studies are naturalistic, cross-sectional studies involving group comparisons.  
 
3.3. Material  
The present studies included an overall number of 398 patients with psychotic disorders. The 
samples in the three studies differed to some extent. This is partly due to the ongoing 
inclusion process and thus increasing number of patients included in the TOP study, but also 
due to different aims and methodology in the different studies (see table 1). Patients included 
in study I and II were recruited from the Oslo region, while study III also included patients 
from Innlandet Hospital Trust.  
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Table 1 Samples in study I, II, and III.  
      
N Patient group Inclusion period 
Study I 174 Schizophrenia spectrum disorders May 2003 - September 2007 
Study II 170 First episode of psychosis September 2004 - July 2008 
Study III 194 First episode of psychosis March 2006 - October 2009 
 
Inclusion criteria specific for study I was a schizophrenia spectrum disorder according to the 
DSM-IV (American Psychiatric Association, 1994), i.e. schizophrenia, schizoaffective 
disorder or schizophreniform disorder. Furthermore, in order to assure valid 
neuropsychological test performance, all patients in study I had to have Norwegian as their 
first language or have received their compulsory schooling in Norway. Additionally, they had 
to have 14 or more correct responses on the forced recognition task on the California Verbal 
Learning Test, second edition (CVLT-II) (Delis, Kramer, Kaplan, & Ober, 2004), as proof of 
adequate test effort.  
An inclusion criterion specific for study II and III was a first episode of a psychotic disorder 
according to the DSM-IV (American Psychiatric Association, 1994), including affective 
disorders with mood-incongruent psychotic symptoms, and excluding psychotic disorders due 
to general medical condition or substance use. Patients were considered to have a first episode 
of psychosis if they had not previously been treated with antipsychotic medication for more 
than 12 weeks or until remission. They were eligible for inclusion up to 52 weeks following 
the start of adequate treatment, defined as admission to hospital due to psychosis or 
antipsychotic medication in adequate dosage.  
The inclusion criterion in common for all three studies was age 18 – 65 years. Exclusion 
criteria common for the three studies were history of severe head injury, brain damage, 
neurological disorder, and mental retardation.  
There was some sample overlap between the three studies. Forty-two patients from study I 
were also included in study II, and 24 patients from study I were included in study III. Ninety-
four patients from study II were also included in study III.  
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3.4. Methods 
The TOP study protocol encompasses measurements of a range of demographic, clinical, and 
neuropsychological variables. Only assessments relevant for the present studies are presented 
in this thesis.  
 
3.4.1. Clinical assessment 
3.4.1.1. Diagnoses 
Diagnoses were set according to the Structured Clinical Interview for DSM-IV Axis I 
Disorders (SCID-I), modules A-E  (First, Spitzer, Gibbon, & Williams, 1995). All 
interviewers completed a training course in SCID-I assessment. In order to assure diagnostic 
inter-rater reliability, regular diagnostic consensus meetings were held. In addition, all 
interviewers received individual supervision by senior clinicians on diagnostic matters. Mean 
overall kappa for SCID-I diagnosis was 0.77. In order to assess reliability of diagnosis for 
actual study participants, a stratified random sample of cases from every interviewer was 
drawn, and clinical vignettes were rated by two experts blind to the study assessments. For 28 
vignettes the overall agreement for DSM-IV diagnoses was 82% and the overall kappa 0.77 
(95% CI: 0.60 – 0.94). 
 
3.4.1.2. Symptoms and functioning 
Psychotic and related symptoms the last seven days were rated on the Positive and Negative 
Syndrome Scale (PANSS) (Kay, Fiszbein, & Opler, 1987), based on information from the 
Structured Clinical interview for the Positive and Negative Syndrome Scale (SCI-PANSS) 
(Kay, 1991). The PANSS is a 30-item rating scale where each item is rated from 1 (“Absent) 
to 7 (“Extreme”). Symptoms were characterised on the PANSS positive subscale, negative 
subscale, and general psychopathology subscale. The inter-rater reliability for PANSS was 
adequate with intraclass coefficient (ICC) of 0.82 (95% CI: 0.66 – 0.94) for the positive 
subscale, 0.76 (95% CI: 0.58 – 0.92) for the negative subscale, and 0.73 (95% CI: 0.54 – 
0.90) for the general psychopathology scale).  
 
Insight was assessed by the PANSS item G12 (Lack of judgement and insight), and a lower 
score indicated more insight.  
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Current depression (last seven days) was assessed by PANSS item G6 (Depression) in study I. 
In study II and III, current depression (past two weeks) was measured by the Calgary 
Depression Scale for Schizophrenia (CDSS) (Addington, Addington, & Schissel, 1990), a 9-
item rating scale where each item is rated from 0 (“Absent”) to 3 (“Severe”).  
 
Global level of symptoms and functioning was measured by the Global Assessment of 
Functioning scale (GAF), split version with symptom scores assessed on the GAF symptom 
scale (GAF-S) (study I) and functioning assessed on the GAF functioning scale (GAF-F) 
(study I and III) (Pedersen, Hagtvet, & Karterud, 2007). Each scale is scored from 0 – 100, 
with higher scores indicating fewer symptoms/better functioning. ICC for GAF-S was 0.86 
(95% CI: 0.77 – 0.92) and 0.85 (95% CI: 0.76 – 0.92) for GAF-F.  
  
Premorbid functioning was measured with the Premorbid Adjustment Scale (PAS) (Cannon-
Spoor, Potkin, & Wyatt, 1982) (study I and II). The PAS is a rating scale that measures level 
of functioning in four age periods, scored from 0 (best level of functioning) to 6 (worst level 
of functioning). The scores were divided into two domains: academic and social. For each 
domain, childhood scores and scores of premorbid change (the difference between latest 
available score and childhood score) were calculated (Haahr et al., 2008). For childhood 
functioning, lower scores indicate better functioning. For change in functioning, positive 
scores indicated a decrease in premorbid functioning while negative change scores indicated 
an increase in premorbid functioning.  
 
3.4.1.3. Suicidality 
Suicidality was measured in different ways according to the different aims of the three 
studies. In study I, information on presence of lifetime suicide attempts were obtained in the 
SCID-I interview (First et al., 1995), which is based on all available information, including 
the patient’ responses to the interview and information from medical records. Study I also 
measured current suicidality based on information from item 8 (“Suicide”) on the CDSS 
(Addington et al., 1990) for 69 patients, and item 18 (“Suicidal thoughts”) on the Inventory of 
Depressive Symptoms – Clinician rated (IDS-C) (Rush, Gullion, Basco, Jarrett, & Trivedi, 
1996) for 131 patients. While the CDSS is based on symptomatology the last two weeks,  
IDS-C measures symptoms the last week. The IDS-C items are rated on a 0 – 3 point scale, 
with higher scores indicating more severe symptom levels. For the 26 patients who were 
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evaluated by both questionnaires, suicidality scores were congruent for 22 patients. In cases 
of incongruence, the score indicating presence of suicidality was chosen. The rate of 
concordant and disconcordant ratings of suicidality in CDSS and IDS-C correspond to a 
kappa value of 0.73.  
 
In study II, suicidality was measured by asking the patients whether they had experienced 
suicidal thoughts, suicidal plans, or attempted suicide in three different time periods, i.e. 
before psychosis, during the period of untreated psychosis, and after treatment start. The 
merging of these time intervals constituted the time interval prior to study entry. Based on this 
information, patients were also categorised according to level of suicidality, i.e. non-suicidal, 
suicidal ideation (suicidal thoughts or suicidal plans), and suicide attempts.  
 
In study III, current suicidality was measured by item 8 on the CDSS (Addington et al., 1990).  
 
3.4.1.4. Illness course 
Age at illness onset (study I) and psychosis onset (study II and III) were defined as age at first 
SCID-verified psychotic symptom. Duration of illness (study I) was defined as the difference 
between age at clinical interview and age at illness onset. Age at first depression (study II) 
was defined as age at first SCID-verified depressive symptom. Number of lifetime psychotic 
episodes and depressive episodes (study I and II) were registered based on the SCID-
interview  (First et al., 1995). The time between start of adequate treatment, as defined above, 
and clinical interview was registered in months (study III). In study II and III, DUP was 
measured in weeks from psychosis onset until start of adequate treatment, as defined above. 
Presence of psychosis was defined as a score of ≥ 4 on items P1 (Delusions) , P3 
(Hallucinatory behaviour) , P5 (Grandiosity), P6 (Suspiciousness/persecution), or G9 
(Unusual thought content) on the PANSS (Kay et al., 1987). All raters of DUP were trained in 
the general evaluation of DUP, which included consensus ratings of randomly drawn cases. 
Cases that were difficult to rate were evaluated under supervision of a senior psychiatrist with 
expertise in the first episode psychosis-field.  
 
3.4.1.5. Demographical data, substance use, and medication 
Information on demographical data, substance use, and medication were obtained from a 
detailed clinical interview and hospital records. This information included alcohol use 
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(number of alcohol units) and substance use (times used) during the six months prior to study 
entry. In addition, lifetime diagnoses of alcohol disorder or drug disorder  were established in 
the SCID-I interview (First et al., 1995) (study II). Information about the use of medication at 
the time of neuropsychological testing was used in study I. Antipsychotic medication was 
classified as typical or atypical medication, and also calculated into chlorpromazine 
equivalents.  
 
3.4.1.6. Beliefs about psychosis (Study III)  
Beliefs about psychosis were measured by the self-report questionnaire Attitudes and Beliefs 
about Mental Health problems, schizophrenia version (Jorm, Korten, Jacomb, Christensen, & 
Henderson, 1999). The questionnaire was translated into Norwegian, translated back into 
English, and approved by the author (Appendix 1). The questionnaire is based on a vignette 
describing a person with symptoms fulfilling the ICD-10 (WHO, 1993) and DSM-IV 
(American Psychiatric Association, 1994) diagnostic criteria for schizophrenia. The patients 
had to answer several questions related to the person in the vignette, and the following 
information from the questionnaire was selected for study III:  [a] recognition of the psychotic 
disorder (open question);  [b] assumptions of prognosis if given professional help (rated on a 
six point scale where 1 = “full recovery with no further problems” and 6 = “get worse”); [c] 
assumptions of five negative long-term outcomes for the vignette-person compared to other 
people (scored “more likely”, “just as likely”, or “less likely”. The responses were summed 
and the variable was dichotomised into “not more likely vs. more likely”); and finally [d] 
assumptions about discrimination occurring (“no”/”yes”). 
 
3.4.2. Neuropsychological assessment (study I) 
The neuropsychological test battery was designed in order to include measures of a broad 
range of neurocognitive domains shown to be impaired in psychotic disorders (Bilder et al., 
2000). Tests that were translated into Norwegian and easily applied in clinical settings were 
given priority over experimental paradigms not available for common use.  
 
Current IQ was subdivided into verbal IQ (VIQ) and performance IQ (PIQ), measured by 
Wechsler’s Abbreviated Scale of Intelligence (WASI) (Wechsler, 2007). VIQ is the sum of 
scores on the Vocabulary and Similarities sub items. The score on Vocabulary is the sum of 
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points achieved for explaining list of 42 words. The score on Similarities is the sum of points 
achieved for explaining what each of 26 pair of words has in common. PIQ is the sum of 
scores on Block Design and Matrix reasoning. The score on Block Design is points achieved 
constructing replicas of 13 block constructions made by the examiner and print designs. The 
score on Matrix Reasoning is points achieved from choosing from multiple-choice array the 
items that best complete 35 different visual patterns.  
 
Premorbid IQ was estimated with the National Adult Reading Test (NART), based on errors 
in reading 50 phonetically irregular words, and adjustet for age years of education and age 
(NART premorbid IQ = 107.5 – [NART errors ×0.52] + [education × 1.16] – [age × 0.1])  
(Sundet & Vaskinn, 2008).  
 
Executive functioning was measured by the Color-Word Interference Test (C-W-Interference 
test) from the Delis Kaplan Executive Functioning Scale (D-KEFS) (Delis, Kaplan, & 
Kramer, 2005). Scores from condition 3 (Interference) were used, the score being time taken 
to name the colour of the ink on a list of written names of colours that are incongruent with 
the colour of the ink. Also included was condition 4 (Set-shifting), where the measure used 
was time taken to complete the alternation between naming the colour of the ink and naming 
the written word. In addition, from the Verbal Fluency Test (D-KEFS) (Delis et al., 2005), the 
third condition (Category switching) was used, where the score was the total number of fruit 
and furniture generated within 60 seconds while alternating between the two categories. 
Finally, executive function was measured by CVLT-II (Delis et al., 2004), where a list of 16 
words is read five times, and the categorisations of words after the reading trials were 
measured. The scores were degree of recall according to semantic categories (Semantic 
cluster ratio), recall according to the order of words read (Serial-order cluster ratio), and 
degree of idiosyncratic recall (Subjective cluster ratio). Also measured was the average 
number of new words per trial acquired across the five reading trials (Learning slope), and the 
percentage of the same words recalled across the reading trials of the list (Recall consistency). 
 
As impulsivity is suggested to arise from impairments in inhibition of inappropriate responses 
(Enticott & Ogloff, 2006), inhibitory control was measured by errors on condition 3 
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(Interference) and condition 4 (Set-shifting) on the C-W Interference Test (D-KEFS) (Delis et 
al., 2005).   
 
Motor functioning was measured by Grooved Pegboard (Matthews & Kløve, 1964). The score 
was seconds to complete insertion of pegs into a board, averaged for both hands.  
 
Psychomotor tempo measured by Digit Symbol on Wechsler Adult Intelligence Scale, Third 
edition (WAIS-III) (Wechsler, 2003). The score was number of correct digits filled in 
according to a key pairing symbol and digit within 120 seconds.  
 
Attention was measured by the Digit Span Test (WAIS-III) (Wechsler, 2003). The total 
number of digits repeated in the same order as presented (forward and backwards) was scored.  
 
Verbal memory was assessed by the Total list A 1 – 5 from the CVLT-II (Delis et al., 2004). 
The measure was the total number of words repeated immediately after five reading trials of a 
list of 16 words.  
 
3.5. Procedures 
Patients with a suspected or confirmed psychotic disorder were asked by their clinician in 
charge of treatment about participation in the TOP study. Interested patients were then 
referred to the study assessment team. Study assessment took place at the patients’ treatment 
units or at the premises of the TOP study.  For patients with a first episode of psychosis, the 
assessment was carried out as soon as possible after treatment start. The clinical assessment 
was conducted by psychiatrists or psychologists who had completed the training and 
reliability program in the TOP study. The clinical interview was carried out over the shortest 
period possible in order to avoid dispersion of symptom measures, but was divided into  
several appointments when required according to the patients’ condition.  
 
The neuropsychological assessment was conducted within 14 days of the clinical assessment 
and was conducted by psychologists with training in standardised neuropsychological testing. 
Test scoring was initially calibrated across the investigators in order to assure inter-rater 
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reliability, and the test-administrators were supervised by a specialist in neuropsychology. A 
report of the results from the clinical assessment and one from the neuropsychological 
assessment were sent to the treatment units with the patients’ consent. The result of the 
assessments was also given in person to the patients and their treating clinicians.  
 
3.6. Ethical considerations 
The TOP study has been approved by the Regional Committee for Medical Research Ethics 
and the Norwegian Data Inspectorate. All participants signed written informed consent. 
Participants received thorough information about the study aim, voluntary participation, the 
different assessments of the TOP study, confidentiality and security of data handling, and the 
right to withdraw from the study at any point in time.  Patients with psychotic disorders may 
have cognitive impairments, and written information was thus supplemented by oral 
information when required.  
 
The patients were approached at their treatment units about study participation. It was 
therefore emphasised that participation was voluntary and that refusal would not have 
consequences for their treatment. Patients did not get monetary compensation for their 
participation, with the exception of travelling expenses.  
 
The TOP study has a comprehensive assessment protocol. Patients were approached at both 
inpatient and out patient units, reflecting different phases and severity of psychotic illness. 
Despite the comprehensive and time consuming assessment, the burden for the patients was 
considered not to exceed that of a thorough clinical examination. The assessment was carried 
out according to the patients’ level of illness, i.e. over several appointments and with breaks 
when needed.  
 
3.7. Statistical analyses 
Statistical analyses were performed with the Statistical Package for Social Sciences (SPSS) 
(SPSS Inc, Chicago, Il, USA) versions 15 and 16. Group comparisons of demographical, 
clinical, and neurocognitive variables were conducted with a range of analyses. All tests were 
2-tailed, and level of significance was set at 0.05. Categorical variables were analysed with 
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Chi-square tests.  For comparison of two groups, continuous variables that were normally 
distributed were analysed with Student t-tests, while skewed variables were analysed with 
Mann-Whitney U tests. For comparison of three groups, normally distributed continuous 
variables were analysed with one-way analyses of variance (one-way ANOVA) with post hoc 
Scheffe’s tests, while skewed variables were analysed with Kruskal-Wallis tests and post hoc 
Mann U-Whitney tests. Exploration of interaction effects between two independent variables 
were conducted with two-way ANOVA. Correlations between variables were investigated 
with Pearson correlation or Spearman rank order correlation analyses, depending on type of 
variables. In order to control for possible confounding variables in study I, a series of 
hierarchical multiple regression analyses was used. The predictive value of variables was 
investigated with binary regression analyses in study II and III. Highly skewed variables were 
logarithm transformed for the regression analyses. Detailed descriptions of the statistical 
analyses used in the studies are presented in the three papers.  
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4. RESULTS/SUMMERY OF PAPERS 
Paper I: Neurocognitive functioning and suicidality in schizophrenia spectrum disorders 
Introduction: Suicidal behaviour and neurocognitive impairment are serious and prevalent 
problems in schizophrenia. Studies indicate that suicidality in schizophrenia may be 
associated with relatively higher neurocognitive functioning, but the findings are few and 
inconsistent. Also, behavioural- and personality measures of impulsivity have been linked to 
increased suicidal behaviour in schizophrenia, but this relationship has not been studied by 
neuropsychological measures. The aim of this study was to investigate whether suicide 
attempters had higher IQ, better executive functioning, or were more impulsive as measured 
by neuropsychological tests than non-attempters in a group of patients with schizophrenia 
spectrum disorders.   
Method: One hundred seventy-four patients with schizophrenia spectrum disorders were 
assessed with a clinical interview for diagnosis, suicidality, symptoms and function, and 
underwent an extensive neurocognitive test battery.    
Results: There were no statistically significant differences in any neurocognitive domains 
between lifetime suicide attempters and non-attempters, or between patients with different 
rates of suicide attempts. Currently suicidal patients were significantly more impulsive (had 
poorer inhibitory control) than currently non-suicidal patients, but this difference was 
mediated by positive psychotic symptoms. 
Conclusion: The findings indicate that among patients with schizophrenia spectrum disorders, 
there are no significant differences in IQ or neurocognitive functioning between suicide 
attempters and non-attempters.  
 
Paper II: Suicidality before and in the early phases of first episode psychosis 
Introduction: The suicide risk in psychotic disorders is highest in the early phases of illness. 
Studies have typically focused on suicidality from treatment start rather than actual onset of 
psychosis. This study explored the prevalence and characteristics of suicidality in patients 
with a first episode of psychosis in two time intervals: 1) prior to study entry and 2) explicitly 
in the period of untreated psychosis.  
  
42 
 
Method: One hundred seventy FEP-patients were interviewed as soon as possible after 
treatment start. The interview included assessments of diagnoses, suicidality, symptoms, 
substance use, and premorbid functioning. 
Results: Nearly 26% of the patients attempted suicide prior to study entry and 14% made 
suicide attempts during the period of untreated psychosis. Of the patients who had been 
suicidal (i.e. experienced suicidal ideation or attempts), 70% were suicidal during the period 
of untreated psychosis. Suicide attempts prior to study entry were associated with female 
gender, more depressive episodes, younger age at psychosis onset, and history of alcohol 
disorder. Suicide attempts during untreated psychosis were also associated with more 
depressive episodes and younger age at illness onset, in addition to drug use the last six 
months and longer duration of untreated psychosis.   
Conclusion: The prevalence of suicidality before and in the early phases of FEP is high, 
especially during untreated psychosis. As prolonged DUP is associated with suicide attempts 
during the period of untreated psychosis, reducing the DUP could have the effect of reducing 
the prevalence of suicide attempts in patients with FEP.  
 
Paper III: Suicidality in first episode psychosis is associated with insight and negative 
beliefs about psychosis 
Introduction: Suicidal behaviour is prevalent in psychotic disorders. Insight has been found to 
be associated with increased risk for suicidal behaviour, but not consistently. A possible 
explanation for this is that insight has different consequences for patients depending on their 
beliefs about psychosis. The present study investigated whether a relationship between 
insight, negative beliefs about psychosis and suicidality was mediated by depressive 
symptoms, and if negative beliefs about psychosis moderated the relationship between insight 
and suicidality in patients with a first episode of psychosis.  
Method: One hundred ninety-four FEP-patients were assessed with a clinical interview for 
diagnosis, symptoms, functioning, substance use, suicidality, insight, and beliefs about 
psychosis.  
Results: Nearly 46% of the patients were currently suicidal. Depressive symptoms, having a 
schizophrenia spectrum disorder, insight, and beliefs about negative outcomes for psychosis 
were independently associated with current suicidality; contradicting a mediating effect of 
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depressive symptoms. Negative beliefs about psychosis did not moderate the effect of insight 
on current suicidality.  
Conclusion: The results indicate that more depressive symptoms, higher insight, and negative 
beliefs about psychosis increase the risk for suicidality in FEP-patients. The findings imply 
that monitoring insight should be part of assessing the suicide risk in patients with FEP, and 
that treating depression and counteracting negative beliefs about psychosis may possibly 
reduce the risk for suicidality.  
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5. DISCUSSION  
5.1. Discussion of main findings 
5.1.1. Neurocognitive functioning and suicidality in schizophrenia spectrum disorders  
In study I, we found that suicide attempters did not have higher IQ than non-attempters in a 
sample of patients with schizophrenia spectrum disorders. This finding is in keeping with 
other studies of suicide attempts (Potkin et al., 2003; Nangle et al., 2006), but inconsistent 
with studies finding an association between higher IQ and completed suicide (De Hert et al., 
2001). However, as suicide attempts occur at a far higher rate then completed suicide, it is not 
unexpected that the predictors of attempts differ from predictors of suicide (McGirr & 
Turecki, 2008).  
 
We also found that suicide attempters did not have better executive function compared to non-
attempters, consistent with the findings of Potkin et al. (2003). This result contradicts a strong 
relationship between level of executive function and propensity to carry out suicidal acts. Our 
result is inconsistent with one other study finding a relationship between sub-components of 
executive function (attention and verbal fluency) and suicide attempts (Nangle et al., 2006). 
Executive function comprises of multiple processes (Kerns, Nuechterlein, Braver, & Barch, 
2008), and it is possible that Nangle et al. (2006) used neuropsychological tests that measured 
executive processes that were more closely related to engagement in suicidal acts. Study I, 
however, included several different measurements of executive function, assessing different 
executive processes. If executive function did play an essential part of engaging in suicidal 
acts, we could expect this to come across in different test. Also, studies have indicated that 
poorer executive function is related to being currently suicidal (Marzuk, Hartwell, Leon, & 
Portera, 2005; Westheide et al., 2008). Nangle et al. (2006) did not control for the possible 
effect of current suicidality, and without this information, it is difficult to compare our results 
directly with theirs. 
 
Study I is the first to examine neuropsychologically measured impulsivity in relation to 
suicidality in a sample consisting of only patients with schizophrenia spectrum disorders. We 
did not find suicide attempters to be more impulsive, i.e. to have poorer inhibitory control 
than non-attempters, indicating that impulsivity is not an essential part of attempting suicide 
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in patients with schizophrenia spectrum disorders. However, this result contradicts previous 
findings of a relationship between neuropsychologically measured impulsivity and suicide 
attempts in other populations (Dougherty et al., 2004; Raust et al., 2007; Swann et al., 2005; 
Wu et al., 2009). Again, it is possible that the tests used in the other studies measure processes 
that are more relevant for carrying out suicidal acts. Our result is also inconsistent with the 
findings of an association between personality measured impulsivity and suicidality in 
patients with schizophrenia (Gut-Fayand et al., 2001). A possible explanation of our finding is 
that impulsivity does not characterise all suicide attempters, but that impulsive patients 
constitutes a high risk subgroup (Horesh, 2001) whose impulsive features are masked by the 
group as a whole. One possible subgroup is repeaters of suicidal behaviour, who have shown 
to be more impulsive than non-repeaters (Evans, Platts, & Liebenau, 1996). This finding was 
not supported in study I; we did not find a difference in impulsivity between patients without 
suicide attempts, patients with a single attempt, and patients with multiple attempts. However, 
despite the reasonable large sample size, the group of patients with multiple attempts was 
small (n = 24), and lack of association with impulsivity may have been due to lack of 
statistical power.  
 
Another possible explanation why our result contradicts studies of personality measured 
impulsivity is that measurements of inhibitory control may not be comparable to personality 
measures of impulsivity. This is as suggested by a recent study finding that non-psychotic 
suicide attempters were more impulsive than non-attempters on both personality measures 
and neuropsychological measures, but the measurements of impulsivity did not correlate (Wu 
et al., 2009). Although inhibitory paradigms are commonly used to study impulsivity, it is 
unclear which inhibitory paradigm is the one most closely related to impulsive behaviour, and 
whether inhibitory control underlies all impulsive behaviour (Enticott & Ogloff, 2006). It is 
also possible that impulsivity is not a unitary construct, but rather includes several 
components or dimensions that demand different measurements (Wu et al., 2009).  
 
A final explanation of the discrepancy between our results and previous findings is that even 
though impulsivity has been considered to be a relatively stable trait, it could be less stable 
than initially thought (Gut-Fayand et al., 2001). In keeping with this view, it has been 
suggested that there is a distinction between having an impulsive cognitive style and making 
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impulsive suicide attempts, and that these dimensions do not overlap completely  (Baca-
Garcia et al., 2005).   
 
The lack of difference between suicide attempters and non-attempters in IQ, executive 
functioning, and impulsivity was not confounded by group differences in demographical and 
clinical variables. Studies have found that impaired neurocognitive function has been 
associated with current suicidal state (LeGris & van Reekum, 2006; Marzuk et al., 2005; 
Westheide et al., 2008) and consequently, an investigation of the relationship between 
neurocognitive function and suicide attempts also needs to consider the possible confounding 
effect of current suicidal  symptoms (Bryan, 2007). However, we found that the lack of 
relationship between neurocognitive function and lifetime suicide attempts was not 
confounded by differences in current suicidality.  
 
A post hoc result of note in study I was that patients who were currently suicidal were more 
impulsive, i.e. had poorer inhibitory control, than patients who were currently non-suicidal, 
and this difference was mediated by differences in PANSS positive psychotic symptoms. The 
findings regarding presence of psychotic symptoms in relation to suicide have been 
inconsistent (Hawton et al., 2005a), but some studies report that active psychotic illness can 
be highly prevalent in the immediate time preceding suicide (Heila et al., 1997). If patients 
with current suicidality and higher levels of positive symptoms are more impulsive, this 
combination of symptoms could constitute an increased risk for suicidal acts. However, this 
finding was not based on an a priory hypothesis and should thus be interpreted with caution.  
 
In sum, suicide attempters and non-attempters did not differ in IQ, executive function, 
impulsivity or any other neurocognitive domains measured in this study.  
 
5.1.2. Suicidality before and in the early phases of first episode of psychosis 
In study II, we found that suicidal behaviour was highly prevalent in patients with first 
episode psychosis. In the period prior to study entry, almost 39% of the patients had 
experienced suicidal ideation, while nearly 26% had attempted suicide. The prevalence of 
suicide attempts in the early phases of psychosis varies across different studies (Nielssen & 
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Large, 2009). Our result is in the higher range, but comparable to rates in similar samples 
(Nordentoft et al., 2002). The rates of suicidality confined to the period of untreated psychosis 
was also high; more than 31% of patients had experienced suicidal ideation, while over 14% 
had attempted suicide. This rate of suicide attempts is somewhat higher than rates found by 
others (10% and 7%) (Clarke et al., 2006; Foley et al., 2008). Of all the patients who had 
experienced suicidal ideation or attempted suicide before study entry, 70% had been suicidal 
during the period of untreated psychosis. In addition, of all the attempters, more than 54% had 
attempted suicide within the period of untreated psychosis. This underlines that suicidality is 
especially prevalent after the onset of psychosis and before treatment is initiated.  
 
Suicide attempts made prior to study entry and specifically during untreated psychosis were 
associated with younger age at psychosis onset and more depressive episodes. While 
attempting suicide before study entry was specifically associated with female gender and a 
lifetime history of alcohol disorder, attempts made during untreated psychosis were associated 
with the use of drugs the last six months prior to study entry. The most important difference 
between attempting suicide prior to study entry and during the period of untreated psychosis 
was that only suicide attempts made specifically during untreated psychosis were associated 
with prolonged DUP. In line with Clarke et al. (2006) we found that the DUP became 
significantly longer with each level of increasingly severe suicidality, with a median DUP of 
more than four years for patients who attempted suicide during untreated psychosis.   
Previous studies on the relationship between DUP and suicide attempts have yielded 
apparently inconsistent results. Some studies have found an association between longer DUP 
and suicide attempts (Altamura et al., 2003; Clarke et al., 2006; Harvey et al., 2008), while 
other studies have not (Bakst et al., 2009; Foley et al., 2008; Nordentoft et al., 2002). A recent 
study even found that shorter DUP was correlated with suicide attempts (Preti et al., 2009), 
but this finding could be explained by the exclusion of patients with substance dependency, a 
group with increased risk for suicide attempts (Verdoux et al., 1999) and prolonged DUP 
(Cougnard et al., 2004). Our finding of a relationship between prolonged DUP and higher risk 
for suicide attempts are in line with the only two studies that measured predictors of suicide 
attempts specifically during untreated psychosis (Clarke et al., 2006; Harvey et al., 2008). The 
studies that did not find a relationship between DUP and suicide attempts measured attempts 
in phases extending beyond the period of untreated psychosis, and our finding of a non-
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relationship between DUP and attempted suicide prior to study entry is thus consistent with 
their findings. In sum, this finding from study II indicates that the duration of untreated 
psychosis has relevance for the suicide risk specifically during the period of untreated 
psychosis.  
 
A possible explanation for the relationship between prolonged DUP and suicide attempts 
during untreated psychosis is that the DUP is a proxy factor for another variable associated 
with both the DUP and suicidal acts.  For instance, Clarke et al. (2006) suggest that patients 
with long DUPs may have more malignant forms of illness likely to be associated with 
suicidality. If so, it is likely that DUP would be associated not only with suicide attempts 
during untreated psychosis, but also with suicide attempts prior to study entry. This was not 
the case in the present study. Other explanations for the association between DUP and suicide 
attempts during untreated psychosis could be longer opportunity time per se, or alternatively 
longer exposure to psychosis (Clarke et al., 2006). Experiencing psychotic symptoms is 
traumatic and distressing (Birchwood, 2003), and a majority of patients develop depression 
concurrent with acute psychosis (Birchwood, Iqbal, Chadwick, & Trower, 2000). 
Furthermore, a majority of patients experience loss of hope and aspirations, disruption, and 
social isolation as a consequence of onset of FEP (Tarrier, Khan, Cater, & Picken, 2007). In 
line with this, patients with FEP have diminished quality of life already at treatment start, and 
diminished quality of life has been associated with prolonged DUP (Browne et al., 2000). It is 
possible that experiencing psychotic- and related symptoms over longer periods of time, 
before treatment commences, increases the risk for attempting suicide. Finally, FEP-patients 
with poor premorbid functioning and at-risk behaviour (e.g. substance use) are more likely to 
have delayed treatment start and hence long DUP (Cougnard et al., 2004). It is possible that 
the patients with prolonged DUP in our study had levels of functioning or behaviours that 
delayed them from coming to treatment, unless they finally attempted suicide. Study II cannot 
conclude on this matter, as we did not register specifically whether suicidality was part of the 
reason for coming to treatment.  
 
In sum, our findings indicate that the prevalence of suicidality in FEP-patients is high, 
especially during the period of untreated psychosis. Suicide attempts made during this period 
was associated with prolonged DUP.  
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5.1.3. Insight, beliefs about psychosis, and suicidality in first episode psychosis 
Study III is the first to investigate the relationship between insight, beliefs about psychosis, 
depressive symptoms, and suicidality in a sample of FEP-patients. Nearly 46% of the patients 
were currently suicidal, in line with previous research showing that suicidality is common in 
patients with FEP (Nielssen & Large, 2009). We found that depressive symptoms did not 
mediate between insight and suicidality or between beliefs and suicidality, i.e. more current 
depressive symptoms, higher insight, and beliefs about negative outcomes for psychosis were 
independently related to current suicidality. Current depressive symptoms were strongly 
associated with current suicidality, in keeping with several other studies reporting that 
depression increases the risk for suicidal behaviour (Hawton et al., 2005a). Depression has 
been related to both insight and to negative beliefs in general, i.e. higher insight is associated 
with higher levels of depression (Mintz et al., 2003), and depression is characterised by 
negative cognitive biases, e.g. negative beliefs and attitudes (Beck, 2005). Thus, a possible 
explanation for the relationship between insight and suicidality could have been that patients 
with insight were more depressed and therefore more suicidal. Similarly, the relationship 
between negative beliefs about psychosis and suicidality could be explained by more negative 
beliefs reflecting more depression in the suicidal patients. However, this was not the case in 
study III; insight and beliefs about negative outcomes for psychosis were associated with 
current suicidality after controlling for the level of depressive symptoms. This indicates that 
although depression is clearly associated with suicidality, risk factors for suicidality in FEP-
patients go beyond mere feelings of depression and include the patients’ evaluations of their 
own personal disorder and of psychotic disorders in general.   
 
Our finding of an association between higher insight and current suicidality is consistent with 
other studies (Foley et al., 2008; Robinson et al., 2009). Crumlish et al. (2005) found that 
insight at one point in time predicted later suicide attempts. Thus, a reasonable interpretation 
of our result is that higher overall insight may lead to suicidality. The finding that beliefs 
about negative outcomes for psychosis were associated with current suicidality is in keeping 
with a study finding a relationship between personal negative illness perceptions and suicidal 
ideation (Fialko et al., 2006). A plausible interpretation of our finding is that patients with 
FEP may view outcomes of psychotic disorders to be very negative, to the extent that suicide 
is considered a way out. We expected that only patients with high insight and negative beliefs 
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about psychosis would be suicidal, as negative beliefs about psychosis would have personal 
significance only to patients with high insight. Contrary to this expectation, we found that 
patients with higher insight had a higher risk of being suicidal regardless of their beliefs about 
psychosis. In view of this, it is noteworthy that some patients had not been informed about 
their diagnosis when they were assessed in the study. However, information about diagnosis 
does not automatically change level of insight, as indicated by the inconsistent effect of 
psychoeducation in achieving this goal (Henry & Ghaemi, 2004). Also, patients may be aware 
of having a mental disorder without knowing their exact diagnosis. Hence, it is unclear how 
variation in knowledge about diagnosis influenced the relationship between insight, beliefs 
about psychosis and suicidality in study III. An alternative and more probable explanation of 
our finding is that our measurement of beliefs did not tap self-stigmatising beliefs about 
psychosis, but rather more general beliefs about psychosis. 
 
In sum, our findings indicate that more depressive symptoms, higher insight and negative 
beliefs about psychosis increase the risk for suicidality in FEP-patients.  
 
5. 2. Discussion of general methodological issues 
5.2.1. Sample issues; representativity and generalisability 
We have studied samples of the population of patients with psychotic disorders, and biases in 
selecting our samples may have occurred. An important issue is to what degree the present 
samples are representative for the population of patients with psychotic disorders, and 
whether our findings can be generalised to this population.  
 
The patients in the present studies were consecutively recruited from inpatient and outpatient 
psychiatric units. Mental health care in Norway is organised in catchment areas, and all 
inhabitants in a given catchment area are offered public mental health care. This system has 
the advantage of reducing the socio-demographical biases that may affect samples selected 
from either public or private treatment facilities, and increases the likelihood that our samples 
are representative for the population of patients with psychotic disorders. Furthermore, by 
recruiting patients from both in- and out patient units we were able to include patients in 
different phases of the disorder and with different levels of symptomatology, also increasing 
  
51 
 
the sample representativity. Patients were included as soon as possible, i.e. as soon as they 
were capable of completing the TOP assessment protocol. This excluded patients in the most 
acute phase of illness, for instance grossly disorganised or agitated patients. However, as the 
TOP inclusion period extends over several years and treatment units at different levels, the 
patients who were detected in very acute illness phases were offered participation at a later 
point in time. Of note is that the TOP study includes patients in treatment. Consequently, we 
have no data on patients with psychotic disorders who do not receive treatment, i.e. 
undetected cases or patients who receive treatment outside of psychiatric units, e.g. at general 
practitioners. However, as psychotic disorders are considered to be severe mental disorder, it 
can be assumed that most individuals with psychotic disorders will be connected with the 
psychiatric services at one point in time.   
 
In recruiting patients to the TOP study, patients with a suspected or confirmed psychotic 
disorder were initially asked by their treating clinician if they were interested in study 
participation. The patients that were interested in participating were then referred to the TOP 
study assessment team. This ensured the rapid referral of a large group of patients. However, 
this procedure is dependent on the clinician’s ability to recognize eligible patients and 
motivation to forward them to the assessment team. In order to facilitate the inclusion of all 
eligible patients, the members of the TOP assessment team were situated at the clinical units, 
and this made possible frequent contact between the clinical units and TOP study. Clinicians 
may have failed to recognize some patients as eligible, in particular patients with a first 
episode of psychosis with apparently unclear symptomatology. However, the close contact 
between clinicians and researchers made it possible to discuss potential cases, hence reducing 
the chance of missing eligible patients. Some clinicians may have refrained from referring 
patients to the study due to some form of scepticism. However, several patients passed the 
clinicians’ pre-screening, but then turned out not to fulfil the inclusion criteria; e.g. they did 
not have a psychotic disorder. This phenomenon gave the impression that rather than referring 
too few patients, clinicians referred too many. Clinicians may have been motivated to refer 
patients by the thorough assessment the patients received, of which the results in most cases 
were reported to the clinicians. An overall impression was thus that eligible patients were 
referred to the TOP study, assuring the samples’ representativity.  
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Some patients refused to participate in the TOP study; they refused when approached by their 
clinician or by TOP interviewers, and a very small group of patients declined to go further 
after an initial assessment. According to regulations from the Norwegian Data Inspectorate, 
we are not allowed to obtain information about patients who do not give informed consent, or 
who refuse to participate in a study. Hence, we have not registered the participation refusal 
rate and have no data on these patients. One alternative could have been to count the refusals 
anonymously. However, as some of the consenting patients who passed the clinicians’ pre-
screening turned out not to have psychotic disorder after all, we can assume that a share of the 
refusers also did not fulfil our inclusion criteria. Hence, counting the refusals without 
registering clinical data would potentially have given misleading information. One hypothesis 
is that the patients with most severe symptomatology and/or functioning are the ones who 
refused, leaving our sample to consist of the patients with lower symptom levels and better 
functioning. The inclusion of patients from in- and out patient units was carried out in order to 
ensure variation in symptomatology. It can be assumed that admitted patients have more 
severe symptoms than patients receiving outpatient treatment. Although this has not been 
investigated systematically, we have no indication that there were more refusers among 
patients receiving inpatient care than outpatient care, which may indicate that our sample is 
not biased regarding illness severity.  
 
The representativity of the patients in the TOP study was investigated by comparing data with 
variables from the Ullevål 600 Health Care Study (Ringen et al., 2008). This survey included 
all patients from all psychiatric units at the former Ullevål University Hospital from May 
2003 until May 2005 with psychotic and affective disorders (F 20 – F 39) according to the 
ICD-10 (WHO, 1993). The total sample included 1002 patients. The TOP sample was 
withdrawn, leaving 849 patients in the reference group. There were no differences in age or 
gender between the TOP sample and the reference group.  Overall, this indicates that the TOP 
sample is representative for the population of patients with psychotic disorders .   
 
Some studies include only patients at high risk for suicidality [e.g (Meltzer et al., 2003)], 
resulting in samples that are relatively homogenous regarding suicidal phenomena. However, 
to assure a representative sample, we did not select patients according to level of suicidality. 
The TOP sample thus consisted of patients who ranged from having no suicidality to having 
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severe suicidality, lifetime and currently, presumably reflecting the natural variance of 
suicidality in the study population. We also included patients with substance use in all three 
studies. This was done in order to assure a representative sample, as substance use is 
prevalent in patients with psychotic disorders  (McCleery, Addington, & Addington, 2006). 
Studies on the effects of substance use on cognition in patients with psychotic disorders have 
yielded inconsistent results (Loberg & Hugdahl, 2009; Ringen et al., 2010); substance use has 
been associated with impaired neurocognitive function  (Wobrock et al., 2007),  but also with 
increased neurocognitive function (McCleery et al., 2006), and neither (Pencer & Addington, 
2003). The association between prior substance use, neurocognitive function, and suicidality 
was analysed in study I, but we did not find substance use to be related to either suicidality or 
neurocognitive function. We have no reason to believe that the inclusion of substance users in 
the pursuit of a representative sample affected our results. In study I, we did exclude patients 
who did not have Norwegian as their first language, or who had not received all of their 
compulsory schooling in Norway. This was done in order to assure valid neuropsychological 
test performance. This meant excluding part of the migrant population, in which the rate of 
schizophrenia is known to be high (McGrath et al., 2004). It is unclear how these excluded 
patients may have differed from the included patients on issues of suicidality.  
 
The samples in study II and III consisted of patients with a FEP. Patients in these samples 
were included up to 52 weeks following start of adequate treatment. The long inclusion period 
was established in order to recruit patients with different illness course, including patients 
with the most severe illness who needed time before they were able to participate in the study. 
The time since treatment start could thus potentially have differed considerably among the 
patients, and differing levels of suicidality could be a reflection of different duration of 
treatment. However, in study III we found that there was no significant difference between 
suicidal and non-suicidal patients in time since treatment start. Median time since treatment 
start for the whole sample was one month, while 75% were included no longer than 3 months 
after treatment start, indicating that the majority of patients was similar in being included in 
the study relatively close to treatment start. This was not explored specifically in study II, but 
we have no reason to believe that the two samples differ on this variable.  
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The samples in study II and III constituted of patients with a first episode of any functional 
psychotic disorder, including affective disorders with mood-incongruent psychotic symptoms. 
A possible consequence of this inclusion criterion is that the samples became too 
heterogeneous, masking important relationships between suicidality and subgroups. The 
inclusion of a range of psychotic disorders is in keeping with several other studies of FEP-
patients (Clarke et al., 2006; Melle et al., 2006; Nordentoft et al., 2002). This made possible 
the recruitment within a limited time frame of a large number of patients from a group which 
basically has a relatively low incidence rate (McGrath et al., 2004), increasing the statistical 
power. However, the reason for this inclusion criterion goes beyond the goal of recruiting 
large samples. The group of patients with FEP vary considerably on a range of variables, e.g. 
age, symptoms, duration of symptoms, and affective symptoms. In samples like the present, 
where many patients have not yet remitted from their first episode of psychosis, diagnoses are 
potentially unstable. Studies report of a significant degree of diagnostic instability in FEP-
patients (Baldwin et al., 2005; Haahr et al., 2008); i.e. as the illness proceeds, the diagnoses 
change. The inclusion of a broad range of diagnoses increases the likelihood of including all 
cases of psychotic disorders, and hence increases the representativity of the samples. In 
support of our strategy, the dichotomising of schizophrenia and bipolar disorder has been 
criticised due to overlapping symptomatology between psychotic and affective disorders 
(Craddock & Owen, 2007). Recent studies also indicate that schizophrenia and bipolar 
disorder may have common aetiology (Craddock et al., 2009). Finally, patients with 
schizophrenia and other psychotic disorders (Radomsky et al., 1999), and patients with 
bipolar disorders (Hawton et al., 2005b) are associated with elevated suicide rates. Based on 
this, it seemed reasonable to include patients with a range of psychotic disorders.   
 
A measure that reduced the heterogeneity of the sample was to include only patients with 
affective disorders with mood-incongruent psychotic symptoms. Due to diagnostic instability, 
patients with affective psychosis (i.e. bipolar disorders or major depressive disorder) could at 
a later point in time be re-evaluated to have a schizoaffective disorder. This particularly 
applies to patients meeting the A-criterion for schizophrenia in DSM-IV (American 
Psychiatric Association, 1994), including bizarre psychotic symptoms and other mood-
incongruent symptoms. According to the DSM-IV B-criterion for schizoaffective disorder, if 
these symptoms last more than two weeks in the absence of prominent mood symptoms, the 
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diagnosis may change to schizoaffective disorders. Because of this, patients with affective 
psychoses with mood-incongruent psychotic symptoms were included in the studies. A 
consequence of this is that our results cannot without further consideration be generalised to 
patients with affective disorders without psychotic symptoms or with mood-congruent 
psychotic symptoms.  
 
5.2.2. Design issues; cause and effect 
The design in the present studies was cross-sectional, with somewhat different consequences 
for interpretation of the results in the three studies. Overall, a cross-sectional design means 
lack of knowledge about the sequence of phenomena, thus limiting conclusions about cause 
and effect. In study I we assessed neurocognitive function when patients entered the study, 
and not concurrent with the suicide attempts. Neurocognitive impairments in schizophrenia 
are considered to be relatively stable over time (Heaton et al., 2001), but some studies suggest 
that neurocognitive function may be related to current suicidal state (LeGris & van Reekum, 
2006; Marzuk et al., 2005; Westheide et al., 2008). Hence, the measurement of 
neurocognitive function may have been different if measured closer in time to the suicide 
attempts. Similarly, we cannot conclude on the causal relationship of our finding of an 
association between current suicidality and impulsivity (inhibitory control), mediated by 
positive symptoms. Within this design, we have no way of knowing whether the patients who 
were currently suicidal would be more impulsive also without suicidal symptoms. In order to 
conclude on this, we would have to measure impulsivity over time and across different states. 
Another limitation due to the cross-sectional design is that patients classified as non-
attempters could be future suicide attempters. A potential number of future attempters now 
classified as non-attempters could thus possibly explain our finding of a non-difference 
between attempters and non-attempters. By following the patients over time, we would have 
had the opportunity to register future suicide attempts.  
 
In study I, we measured lifetime occurrence of suicide attempts, and in study II, we measured 
suicidal ideation and attempts in different periods up until study entry. Suicidality was thus 
measured retrospectively, and information on past suicidality may have been affected by 
memory bias. It is likely that this would have affected data in study II the most, because 
patients were asked in more detail about different suicidal phenomena in different time 
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intervals. However, in both study I and II, the main analyses were conducted on suicide 
attempts, and information about suicide attempts were cross-checked in several sources, i.e. 
both from patients responding on specific questions about prevalence of suicidality over time 
(study II), responses to questions in the SCID-I interview (First et al., 1995), and hospital 
records (study I and II).  
 
In study III we found an association between insight and suicidality, and between beliefs 
about psychosis and suicidality, but our cross-sectional design limits concluding on the causal 
direction of these relationships. This may have been possible if the phenomena had been 
studied over time. We cannot know whether increased insight led to suicidality, or whether 
suicidality led to higher insight. However, the latter scenario seems highly improbable; it is 
unlikely that suicidality pr se would increase insight into a psychotic disorder. Hence, we 
made the causative assumption that insight leads to suicidality in psychotic disorders. This 
assumption is also supported by a follow-up study finding that insight at one point in time 
predicted suicide attempts at follow-up  (Crumlish et al., 2005).  The same causal caveat 
applies to our finding of the relationship between beliefs about psychosis and suicidality; we 
cannot conclude whether negative beliefs led to suicidality or the opposite. It is possible that 
being suicidal involves having negative beliefs about future outcomes in general. However, 
this needs to be resolved within a research design that allows for studying the relationship 
between beliefs about psychosis and level of suicidality over time.  
 
5.2.3. Measurement issues; validity and reliability 
5.2.3.1. General clinical assessment 
The main instruments used in the present studies are all widely accepted within psychosis 
research and have shown satisfactory psychometric properties (see Methods).  In order to 
ensure reliable clinical assessments, all interviewers in the TOP study underwent a general 
training program for the main clinical instruments, i.e. SCID-I, PANSS and GAF. In addition, 
all interviewers received individual supervision on diagnostics from a specialist in psychology 
or psychiatry and diagnoses were also discussed at regular consensus meetings. As described 
in Methods, analyses of inter-rater reliability for the main instruments were conducted, and 
reliability was found to be satisfactory.  
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5.2.3.2. Neuropsychological assessment 
The neurocognitive measures used in study I are also widely accepted and standardised tests, 
measuring domains known to be impaired in patients with psychotic disorders (Bilder et al., 
2000). In addition to basic training in neuropsychological assessment, reliability was ensured 
by initial calibration of scoring, and supervision by a specialist in neuropsychology. A forced 
recognition task (CVLT-II) (Delis et al., 2004) was used in order to exclude patients with lack 
of test motivation. Overall, these means should ensure the validity and reliability of our 
assessments.   
 
Reviews of literature have shown that neurocognitive functioning is related to several forms 
of functional outcome, e.g. occupational functioning, social attainment, and degree of 
independent living (Green et al., 2000; Green et al., 2004). Despite this, cognitive 
performance in a test-situation may be very different from cognitive functioning in a real-life 
setting, and this raises the question about the ecological validity of the neuropsychological 
assessments, i.e. to what degree is data obtained by our tests actually relevant for suicidal 
behaviour in the “real world”? Although the tests applied in this study are used extensively 
and considered to have sound psychometric properties, the validity of a test will vary with the 
use to which it is put (Lezak, 1995). Hence, whether our neuropsychological measures 
actually have bearing on suicidal behaviour outside of a test situation remains unclear. 
Furthermore, the neurocognitive test battery used in this study included measures of a range 
of neurocognitive domains shown to be impaired in psychotic disorders (Bilder et al., 2000). 
However, it is possible that other areas of neurocognitive function have more relevance for 
engaging in suicidal behaviour.  
 
5.2.3.3. Assessment of suicidality 
We measured different expressions of non-fatal suicidality in the present studies. Our main 
concern in focusing on suicidality in psychotic disorders is to increase knowledge in order to 
predict and prevent completed suicide. In view of this, it may be considered a derailment to 
study non-fatal suicidal behaviour. However, as noted in the Introduction, the study of 
completed suicide is methodologically challenging. Despite the elevated suicide risk, the 
number of patients with psychotic disorders who die by suicide is relatively low. The study of 
completed suicide thus involves recruiting very large samples, which in practice is difficult 
for several reasons, if not impossible (Meltzer et al., 2003). Moreover, post-mortem 
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investigations are potentially incomplete and always indirect, including data from other 
sources than the patients themselves. For these reasons, non-fatal suicidal behaviour is 
commonly studied in order to learn more about completed suicide. In support of this 
approach, research indicates that suicidal ideation, suicide attempts and completed suicide are 
associated with each other (Harkavy-Friedman et al., 1999; Hawton et al., 2005a; Nordentoft 
et al., 2002), and that suicidal behaviour of milder severity may be important phases in a 
process leading to completed suicide (Kontaxakis et al., 2004). In keeping with this, 
attempted suicide is found to be one of the most important predictors of completed suicide 
(Hawton et al., 2005a). However, McGirr and Turecki (2008) has pointed out that the rate of 
suicide attempts is greater than the rate of completes suicides, and consequently the predictors 
of attempted suicide may be dubious predictors of completed suicide. Studies have also 
indicated differences, i.e. patients who completed suicide differ from suicide attempters in 
being male (Harkavy-Friedman & Nelson, 1997), more depressed, hopeless, and socially 
isolated (Drake et al., 1986). Thus, whether we can apply our findings to completers of 
suicide remains to be clarified.  
 
We chose to focus on suicide attempts rather than alternative concepts like DSH or 
parasuicide. Unlike DSH and parasuicide, a suicide attempt is defined by the presence of an 
intention to die. Acts classified as DSH and parasuicide will consequently include self-
injurious behaviour that is more heterogeneous than behaviour classified as attempted suicide 
(Silverman, 2006), possibly comprising behaviour clearly without suicidal intent. However, 
the concept of intent is not easily measured; people can experience great ambivalence in their 
wish to die, and suicidal intent may fluctuate over time. Furthermore, accounts of suicidal 
intent after an attempt can be influenced by the context and the consequences of 
acknowledging the intent (McKeon, 2009). This could possibly lead to underreporting of 
suicidal attempts. Information on suicide attempts in the present studies was obtained from 
the patients’ accounts and from hospital records. We may have missed information on suicide 
attempts not reported, but given that we got information from several sources, these are likely 
to be few.   
 
We did not specifically measure the inter-rater reliability of the different suicidality 
measurements in the three studies. The likelihood that our data on attempted suicide are 
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reliable is increased by the fact mentioned above; patients’ accounts were supplied with 
information from hospital records. Suicidal ideation, on the other hand, could not be double-
checked in the same way, and may be more elusive and thus more difficult to assess. 
However, the IDS-C and CDSS used to assess current suicidality have overall been shown to 
have satisfactory psychometric properties in assessing depression (Addington et al., 1990; 
Addington, Addington, & Maticka-Tyndale, 1994; Addington, Addington, Maticka-Tyndale, 
& Joyce, 1992; Rush et al., 1996), which includes the assessment of level of current 
suicidality. Furthermore, we did measure inter-rater reliability for other instruments that 
include assessments of current suicidality, i.e. SCID-I, PANSS, and GAF. As the inter-rater 
reliability for these measurements were satisfactory, we can assume that suicidality 
assessments were also acceptable. Finally, the TOP protocol includes several questionnaires 
and interviews assessing current suicidality. It is likely that going over these questions several 
times enhanced the quality of the data.  
 
Although the IDS-C and CDSS have shown overall satisfactory psychometric properties in 
measuring depression, the single suicidality items have not been validated per se. Suicidality 
rating scales are ultimately developed with the purpose of assessing suicide risk (Preston & 
Hansen, 2005). Although this is the overall aim in this field of research, our particular 
objective in the present studies was to assess the straightforward presence of suicidal ideation 
and acts the last 1 – 2 weeks; an objective that requires less information than the prediction of 
completed suicide. A related issue is the obvious general limitation in the study of suicidal 
ideation; the fact that it is only possible to assess the suicidal ideation that is actually 
disclosed. We have no way of knowing whether the patients held back information on current 
suicidal symptoms. It is possible that the assurance of confidential data handling, the thorough 
examination of different kinds of symptoms, and also touching upon the subject of suicidality 
several times during the clinical interview may have encouraged openness about suicidal 
phenomena.   
 
In order to examine predictors of current suicidality in study III, a series of regression 
analyses was conducted. The dependent variable in these analyses was currently non-
suicidal/suicidal, derived from the suicidality item on the CDSS. The currently non-suicidal 
and suicidal patients differed significantly on depressive symptoms, which were further 
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explored as independent variable in the regression analyses. In order to avoid suicidality as 
part of both independent and dependent variable, depression was measured as the CDSS total 
score minus the suicidality item, resulting in a measurement of depressive symptoms rather 
than depression. This was considered appropriate on the grounds that a diagnoses of DSM-IV 
major depressive episode (American Psychiatric Association, 1994) does not require the 
presence of suicidality, although suicidality is one of the possible symptoms. This underlines 
that depression and suicidality are related but not inseparable phenomena (Maris, 2002; 
Williams et al., 2005).  
  
5.2.3.4. Measuring beliefs about psychosis 
In study III we used the schizophrenia version of the Attitudes and Beliefs abut Mental Health 
problems (Jorm et al., 1999) to measure patients beliefs about psychosis. We translated this 
self-report questionnaire into Norwegian for the purpose of this study, and translated it back 
into English to ensure proper translation, with the approval of the author. The questions in this 
questionnaire were all based on a vignette describing a young man with symptoms fulfilling 
ICD-10 (WHO, 1993) and DSM-IV (American Psychiatric Association, 1994) criteria for 
schizophrenia. It could be argued that patients with lack of insight into their own psychotic 
symptoms may also have difficulty recognising psychotic illness in others. However, the level 
of insight in our sample varied, with the median PANSS insight score of  3, indicating partial 
insight. Furthermore, almost 67% of the sample recognised and labelled the described 
symptoms as psychotic, and an additional 18% recognised some kind of mental disorder, but 
without being able to classify it as psychosis. Of note is also previous findings indicating that 
the recognition of others’ psychotic symptoms is independent of insight into own illness 
(Startup, 1997). Taken together, this indicates that patients with psychotic disorders are 
capable of recognizing psychotic illness in others.  
 
5.3. Strengths, limitations, and future research 
The strength of this thesis is that the present studies included relatively large catchment area- 
based samples of patients with psychotic disorders, consecutively recruited from both in- and 
outpatient psychiatric units, and with heterogeneity in both suicidal and other clinical 
symptoms. This increases the likelihood that the samples were representative of the 
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population of patients with psychotic disorders. Furthermore, all patients underwent 
comprehensive clinical and neuropsychological assessments, resulting in thoroughly 
described samples, and the reliability of our main measurements were found to be good. An 
additional strength was that we measured both lifetime suicide attempts and current 
suicidality in study I, and were thus able to control for the possible confounding effect of 
current suicidal state on the relationship between neurocognition and suicide attempts.  
 
The overall aim of this thesis was to identify possible risk factors for suicidal behaviour, 
which is important in order to prevent self-inflicted deaths in patients with psychotic 
disorders. The main limitation of the thesis is thus that we did not focus on completed suicide, 
but rather on proxy measures of suicide, i.e. suicidal ideation and suicide attempts. On the one 
side, studies have shown that both suicidal ideation and attempts are associated with 
completed suicide (Hawton et al., 2005), indicating that our findings may have  relevance not 
only for suicidal ideation and attempts, but also for suicide. On the other hand, studies have 
indicated that suicide attempters differ from completers in some respects (Drake et al., 1986; 
Harkavy-Friedman & Nelson, 1997). Applying our results to completed suicide should thus 
be done with caution.  
 
A possible limitation if more specific nature is that we did not have the same measurement of 
current suicidality for all the patients in study I, and therefore had to use suicidality scores 
from the IDS-S (Rush et al., 1996) and the CDSS (Addington et al., 1990). For the 26 patients 
who were evaluated with both questionnaires, suicidality scores were incongruent for four 
patients. This incongruence could have been an indication of poor inter rater-reliability in 
assessing current suicidality. However, the IDS-C measure symptoms the last week, while 
CDSS measure symptoms the last two weeks, and this discrepancy probably accounts for the 
incongruent suicidality scores. Another possible limitation is that we used retrospectively 
measured suicidality in some analyses, and data on timing of suicidal behaviour could have 
been affected by memory bias. However, the main analyses involved suicide attempts, and 
information on suicide attempts were cross-checked in multiple sources. The cross-sectional 
design of our studies limits inferences about the causal direction of relationships, e.g. between 
insight and suicidality and between beliefs about psychosis and suicidality. Interpretation of 
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our findings is also partly limited by the use of PANSS in assessing insight, as it measures 
overall insight rather than different dimensions of insight (Wiffen et al., 2010).  
 
The finding of an association between current suicidal state and impulsivity mediated by 
positive symptoms clearly indicates that in line with our study, future studies should include 
measures of current suicidality when investigating the relationship between neurocognition 
and suicidality. To further explore this finding, prospective studies are warranted in order to 
follow the concurrent development of suicidality, clinical symptoms and neurocognitive 
performance. One possible explanation for not finding a relationship between impulsivity and 
suicide attempts is that impulsivity could be less stable than originally thought (Gut-Fayand et 
al., 2001). This implies that future research on the relationship between impulsivity and 
suicidal behaviour should make use of both trait and state measures of impulsivity. 
Furthermore, future research on cognition in suicidal patients with schizophrenia should in 
addition focus on aspects more directly linked to suicidal processes.  
 
Our findings suggest that IQ, executive functioning, and impulsivity as separate cognitive 
domains are not related to suicidal behaviour. However, suicidal behaviour has been related to 
biases in reasoning, for instance a tendency to “jump to conclusions”, in which impulsivity 
may play a part. Also, suicidal individuals are shown to have poor abilities in interpersonal 
problem solving, which may be related to impairments in executive functioning (Bolton et al., 
2007). Hence, future research on cognition and suicidality may benefit from investigating the 
interaction between different cognitive domains and their relationship to suicidal behaviour.  
 
Some studies report that only aspects of insight are associated with suicidal behaviour 
(Amador et al., 1996; Crumlish et al., 2005; Schwartz & Smith, 2004). A suggestion for 
future research is to use a multidimensional insight scale, e.g. measuring recognition of 
having a mental illness, the need for treatment, and ability to recognise symptoms as separate 
domains. This may provide more specific information on the mechanism of the relationship 
between insight and suicidality. Our unexpected finding that higher insight increases the risk 
for suicidality regardless of beliefs about psychosis could be explained by our study possibly 
measuring more general beliefs about psychosis, and not self-stigmatising beliefs about 
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psychosis. In order to investigate this further, future research should include methods that 
specifically measure beliefs about the patients’ own illness.  
 
5.4. Implications 
The findings of this thesis may have implications for interventions to prevent suicidality. The 
lack of relationship between neurocognitive function and suicide attempts implies that 
assessment of suicide risk should be conducted irrespective of whether patients present 
evidence of  cognitive impairment or not. The association between prolonged DUP and 
increased risk for attempting suicide during untreated psychosis is of importance as it 
indicates that early intervention, with the intent to reduce DUP, could have a specific effect 
on preventing suicidal behaviour. Furthermore, we found a relationship between suicide 
attempts and depressive episodes and between current depressive symptoms and current 
suicidality. These findings underline the need to assess and treat depression in FEP-patients. 
However, our findings also suggest that merely treating depression is not sufficient in order to 
prevent suicidality. The association between higher insight and suicidality indicates that 
insight should be monitored as part of assessing the risk for suicidal behaviour. It also implies 
that treatment should persist during phases when insight is gained, even if increase in level of 
insight coincides with the waning of psychotic symptoms. Finally, the finding of an 
association between negative beliefs about psychosis and suicidality suggest a need to 
counteract negative beliefs about psychosis. Although psychotic disorders have a severe 
course for some patients, research shows that a significant proportion of patients treated for 
schizophrenia achieve favourable long term outcome (Harrison et al., 2001). Interventions 
aimed at modifying negative beliefs about psychoses may have the effect of reducing the risk 
for suicidality in patients with psychotic disorders.  
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6. CONCLUSION 
The studies in this theses investigated possible demographical, clinical, and 
neuropsychological risk factors for suicidal behavior in patients with psychotic disorders, with 
special emphasis on patients with a first episode of psychosis.  
 
Suicide attempts in patients with schizophrenia spectrum disorders were not associated with 
IQ, executive function, neuropsychologically measured impulsivity, or any other 
neurocognitive domain. This suggests that neurocognition does not play an essential part of a 
predisposition to attempt suicide, at least not the domains measured in this study.  
 
In contrast, several clinical variables were related to suicidality, and the variables differed 
somewhat for different time intervals. The findings confirmed a high prevalence of suicidality 
in patients with a first episode of psychosis, and the occurrence of suicidality was particularly 
high during the period of untreated psychosis. Attempted suicide prior to study entry was 
associated with female gender, younger age at psychosis onset, more depressive episodes, and 
a history of alcohol disorder. Attempting suicide during the period of untreated psychosis was 
also associated with more depressive episodes and younger age at psychosis onset, and in 
addition the use of drugs the last six months prior to study entry. The most important 
difference between suicide attempts prior to study entry and during the period of untreated 
psychosis was that only suicide attempts made specifically during untreated psychosis were 
associated with prolonged DUP.  
 
Depressive symptoms did not mediate between insight and suicidality, or between beliefs 
about psychosis and suicidality in FEP-patients, i.e., more depressive symptoms, higher 
insight, and negative beliefs about psychosis were independently associated with current 
suicidality. Lastly, beliefs about psychosis did not moderate the relationship between insight 
and suicidality; thus, FEP-patients with higher insight were at higher risk for being suicidal, 
regardless of their beliefs about psychosis.  
 
In conclusion, the particularly high prevalence of suicidality during the period of untreated 
psychosis, and the significance of a prolonged DUP for suicide attempts, indicate that timing 
is an essential feature of interventions to prevent suicidal behavior, specifically suggesting a 
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need to focus on the period of untreated psychosis. Furthermore, suicidality in psychotic 
disorders seems to be determined by multiple factors. Some factors, like depression and 
substance use, are risk factors for suicidality that patients with psychotic disorders have in 
common with the general population. Other factors, like prolonged DUP, illness insight and 
beliefs about psychosis, are more specifically related to psychotic illness. This suggests that 
interventions aimed at preventing suicidal behavior in patients with psychotic disorders must 
be multifaceted and include strategies that specifically target patients with psychotic 
disorders.   
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    Vignette A 
Holdninger og oppfatninger om psykiske problemer.                   (EAB 15.03.06) 
 
Dette spørreskjemaet handler om en hypotetisk person som heter Ola. I boksen nedenfor beskrives 
hvordan han har hatt det den siste tiden.  
 
Ola er 24 år og bor hjemme hos foreldrene sine. Han har hatt noen få 
midlertidige jobber siden han sluttet på skolen, men er arbeidsledig nå. I løpet 
av de siste seks månedene har han sluttet å være sammen med vennene sine. 
Han har begynt å låse seg inne på soverommet og nekter å spise sammen med 
familien eller å bade. Foreldrene hans kan også høre at han går omkring på 
soverommet sitt om natten etter at de har lagt seg. Selv om de vet at han er 
alene, har de hørt at han roper og krangler som om det er noen andre der. Når 
de prøver å oppmuntre ham til å gjøre ting, hvisker han at han ikke vil forlate 
huset fordi naboene spionerer på ham. De tror ikke at han tar stoff, for han 
aldri er sammen med andre eller går noen steder.  
 
 
1. Ut fra informasjonen over, hva er galt med Ola, hvis noe? 
 ..................................................................................................................................................  
 .................................................................................................................................................. 
 
2. Tror du Ola trenger profesjonell hjelp?  Ja  Nei 
 
3. Hvis Ola skulle søke hjelp fra noen av de følgende personene, er det sannsynlig at det vil hjelpe 
Ola, være skadelig for ham, eller ingen av delene? (Sett ett kryss for hver linje) 
 
 Til hjelp Ingen av 
delene 
Skadelig 
a. En vanlig allmennpraktiserende lege eller 
fastlege 
1 2 3 
b. En vanlig apoteker 1 2 3 
c. En rådgiver  1 2 3 
d. En sosialarbeider 1 2 3 
e. Hjelpetelefon, f.eks. Mental Helse 1 2 3 
f. En psykiater 1 2 3 
g. En klinisk psykolog 1 2 3 
h. Hjelp fra hans nære familie 1 2 3 
i. Hjelp fra nære venner 1 2 3 
j. En homeopat eller urtekyndig  1 2 3 
k. En prest 1 2 3 
l. Ola prøver å takle problemene sine på 
egenhånd 
1 2 3 
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4. Hvis Ola skulle ta en av de følgende medisinene, er det sannsynlig at det vil hjelpe Ola, være 
skadelig for ham, eller ingen av delene? (Sett ett kryss for hver linje) 
  
Til hjelp 
 
Ingen av 
delene 
 
Skadelig 
a. Vitaminer og mineraler, kosttilskudd eller 
urtemedisin 
1 2 3 
b. Smertestillende midler  1 2 3 
 Antidepressiva/midler mot depresjon  1 2 3 
d. Antibiotika  1 2 3 
e. Beroligende midler/sovemidler 1 2 3 
f. Antipsykotiske midler  1 2 3 
g. Angstdempende midler  1 2 3 
 
 
 
5. Hvis Ola skulle foreta seg noe av det følgende, er det sannsynlig at det vil hjelpe Ola, være 
skadelig for ham, eller ingen av delene? (Sett ett kryss for hver linje) 
  
Til hjelp 
 
Ingen av 
delene 
 
Skadelig 
a. Bli mer fysisk aktiv   1 2 3 
b. Lese selvhjelps bøker 1 2 3 
c. Komme seg mer ut 1 2 3 
d. Kurs i avslapning, håndtering av stress, 
meditasjon eller yoga 
1 2 3 
e. Slutte å drikke alkohol 1 2 3 
f. Rådgivning 1 2 3 
g. Psykoterapi/samtalebehandling 1 2 3 
h. Hypnose 1 2 3 
i. Innleggelse på psykiatrisk sykehusavdeling   1 2 3 
j. Elektrosjokk behandling (ECT)  1 2 3 
k. Drikke litt alkohol av og til for å slappe av 1 2 3 
l. En spesiell diett eller unngå visse typer mat 1 2 3 
 
6.  Hva ville bli det sannsynlige resultatet hvis Ola fikk den type profesjonell hjelp du synes er mest 
riktig? (Sett kun ett kryss) 
 Fullstendig bedring uten videre problemer 
 Fullstendig bedring, men problemer ville sannsynligvis komme igjen  
 Delvis bedring 
 Delvis bedring, men problemer ville sannsynligvis komme igjen 
 Ingen bedring 
 Bli verre 
 
 
7. Hva ville bli det sannsynlige resultatet hvis Ola ikke fikk profesjonell hjelp? (Sett kun ett kryss) 
 Fullstendig bedring uten videre problemer 
 Fullstendig bedring, men problemer ville sannsynligvis komme igjen 
 Delvis bedring 
 Delvis bedring, men problemer ville sannsynligvis komme igjen 
 Ingen bedring 
 Bli verre 
 
 
8. Anta at Ola fikk den hjelpen du synes er riktigst for hans psykiske problemer.  
Hvordan tror du han vil fremstå på lang sikt sammenlignet med andre mennesker i samfunnet?  
Hvor sannsynlig er det at han: (Sett ett kryss for hver linje) 
 
 
Mer 
sannsynlig 
Like 
sannsynlig 
Mindre 
sannsynlig 
a. er voldelig      1 2 3 
b. drikker for mye 1 2 3 
c. tar ulovlige narkotiske stoffer 1 2 3 
d. har dårlige venneforhold 1 2 3 
e. prøver å ta sitt eget liv 1 2 3 
f. er forståelsesfull i forhold til andre 
menneskers følelser 
1 2 3 
g. har et godt ekteskap 1 2 3 
h. er en omsorgsfull forelder 1 2 3 
i. er en produktiv arbeidstager 1 2 3 
j. er kreativ eller kunstnerisk 1 2 3 
 
 
9. Tror du Ola ville bli diskriminert av andre i samfunnet hvis de visste om problemene han har hatt?     
   Ja    Nei 
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